Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Valvular Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 505 articles:
HTML format



Single Articles


    May 2024
  1. WEI X, Li X, Liang Y, Chen F, et al
    Transcatheter tricuspid valve replacement with LuX-valve device: Overview of key echocardiographic considerations.
    Catheter Cardiovasc Interv. 2024 May 14. doi: 10.1002/ccd.31082.
    PubMed     Abstract available


  2. MOCCETTI F, Wolfrum M, Bossard M, Attinger-Toller A, et al
    Transfemoral-only transcatheter aortic valve replacement: A single center experience of 400 consecutive patients.
    Catheter Cardiovasc Interv. 2024 May 12. doi: 10.1002/ccd.31077.
    PubMed     Abstract available


  3. PEZZOLA E, Tomasoni D, Caneiro-Queija B, Raposeiras-Roubin S, et al
    Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2024 May 12. doi: 10.1002/ccd.31079.
    PubMed     Abstract available


  4. ALNASSER SM, Moey M, Ali N, Almazroa L, et al
    Percutaneous balloon mitral valvuloplasty with shockwave lithotripsy for the treatment of calcific mitral valve stenosis.
    Catheter Cardiovasc Interv. 2024 May 3. doi: 10.1002/ccd.31063.
    PubMed     Abstract available


  5. ENGEL GONZALEZ P, Gregerson S, Mahmood S, Brooks C, et al
    Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions.
    Catheter Cardiovasc Interv. 2024;103:1023-1034.
    PubMed     Abstract available


  6. DONAHUE CL, Westman CL, Faanes BL, Qureshi AM, et al
    Finite element modeling with patient-specific geometry to assess clinical risks of percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2024;103:924-933.
    PubMed     Abstract available



  7. Correction to "Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study".
    Catheter Cardiovasc Interv. 2024;103:1078.
    PubMed    


  8. YANG L, Chen S, Zhang X, Zhang Y, et al
    Comparisons of noncoronary sinus pivot implantation (NCPI) and conventional method for transcatheter aortic valve replacement with self-expanding valve in pure aortic regurgitation (PAR).
    Catheter Cardiovasc Interv. 2024 May 1. doi: 10.1002/ccd.31064.
    PubMed     Abstract available


    April 2024
  9. XIE CM, Zhu D, Wang SZ, Pan XB, et al
    Successful treatment of severe primary mitral regurgitation due to rheumatic aetiology using a novel-designed transcatheter edge-to-edge repair system.
    Catheter Cardiovasc Interv. 2024 Apr 19. doi: 10.1002/ccd.31058.
    PubMed     Abstract available


  10. DAMARKUSUMA A, Johar S, Patel B, Yung CC, et al
    Using Ping-pong technique along with rapid inflate-deflate ballooning to solve total left main occlusion during transcatheter aortic valve replacement procedure.
    Catheter Cardiovasc Interv. 2024 Apr 19. doi: 10.1002/ccd.31059.
    PubMed     Abstract available


  11. IACOVELLI F, Burattini O, Sturda F, Branca M, et al
    Single suture-mediated closure system after transfemoral transcatheter aortic valve implantation: A single-center real-world experience.
    Catheter Cardiovasc Interv. 2024 Apr 19. doi: 10.1002/ccd.31054.
    PubMed     Abstract available


  12. LIMA MR, Brito J, Almeida M, Teles RC, et al
    Combined transcatheter aortic valve and tricuspid valve-in-valve implantation in a patient with a mitral mechanical prosthesis.
    Catheter Cardiovasc Interv. 2024 Apr 19. doi: 10.1002/ccd.31057.
    PubMed     Abstract available


  13. BRIEDIS K, Rumbinaite E, Aldujeli A, Briede K, et al
    One-year initial efficacy and safety outcomes of the premounted dry-pericardium Vienna self-expandable transcatheter aortic valve system: A first-in-human VIVA feasibility study.
    Catheter Cardiovasc Interv. 2024 Apr 9. doi: 10.1002/ccd.31039.
    PubMed     Abstract available


  14. BUCHANAN CE, Iskander M, Anwaruddin S, Mason PJ, et al
    Novel valve-in-surgical bioprosthetic transcatheter aortic valve replacement: Undermining iatrogenic coronary obstruction with radiofrequency needle (UNICORN).
    Catheter Cardiovasc Interv. 2024 Apr 8. doi: 10.1002/ccd.31038.
    PubMed     Abstract available


  15. BOIAGO M, Bellamoli M, De Biase C, Beneduce A, et al
    Three-year clinical outcomes after transcatheter aortic valve implantation in patients with bicuspid aortic disease: Comparison between self-expanding and balloon-expandable valves.
    Catheter Cardiovasc Interv. 2024 Apr 5. doi: 10.1002/ccd.31041.
    PubMed     Abstract available


  16. TEBAR D, Carrillo X, Garcia Del Blanco B, Gomez-Hospital JA, et al
    Experience with the ACURATE neo and neo2 transcatheter aortic valves in Spain. The PRECISA (PRospective Evaluation Complementing Investigation with ACURATE devices) registry.
    Catheter Cardiovasc Interv. 2024 Apr 5. doi: 10.1002/ccd.31032.
    PubMed     Abstract available


  17. OZTAS DM, Ozdemir E, Bauernschmitt R, Ugurlucan M, et al
    Transcatheter aortic valve implantation for pure aortic insufficiency in a patient following David-type aortic valve-sparing root replacement after aortic dissection-A successful off-label procedure.
    Catheter Cardiovasc Interv. 2024 Apr 5. doi: 10.1002/ccd.31033.
    PubMed     Abstract available


  18. KORNOWSKI R
    Extent of cardiac damage before transcatheter aortic valve replacement: Beyond aortic stenosis per se.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31031.
    PubMed    


  19. BAEKKE PS, Gran LL, Jorgensen TH, Ghattas A, et al
    Extent of cardiac damage and hospitalization burden in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31015.
    PubMed     Abstract available


  20. BHOGAL S, Garg M, Meda NS, Merdler I, et al
    Reasons for repeat urgent cardiac procedures within the same day.
    Catheter Cardiovasc Interv. 2024;103:691-694.
    PubMed     Abstract available


    March 2024
  21. BIANCARI F, Makikallio T
    Hospital racial composition and outcomes after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Mar 29. doi: 10.1002/ccd.31022.
    PubMed    


  22. BASMAN C, Landers D, Kliger C, Rodriguez-Barragan K, et al
    Balloon rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Mar 28. doi: 10.1002/ccd.31029.
    PubMed     Abstract available


  23. HANSON I, Goldstein JA
    Trans-catheter repair of tricuspid regurgitation following left heart valve surgery: Expansion of the interventionist portfolio.
    Catheter Cardiovasc Interv. 2024 Mar 15. doi: 10.1002/ccd.31013.
    PubMed    


  24. EL SHERBINI AH, Servito M, Zidan A, Elsherif S, et al
    Sex differences in the outcomes after transcatheter aortic valve replacement with newer generation devices: A meta-analysis.
    Catheter Cardiovasc Interv. 2024 Mar 10. doi: 10.1002/ccd.30985.
    PubMed     Abstract available


  25. ROSS DS, Nogic J, Cong H, Nuzzi V, et al
    Ultrasound-guided deployment of ProGlide device in transfemoral transcatheter aortic valve implantation and risk reduction of vascular complications: A propensity-matched cohort study.
    Catheter Cardiovasc Interv. 2024 Mar 7. doi: 10.1002/ccd.30999.
    PubMed     Abstract available


  26. MUSTAFA A, Basman C, Cinelli MP, Goldberg Y, et al
    Contemporary experience of mitral transcatheter edge-to-edge repair technology in patients with mitral annular calcification.
    Catheter Cardiovasc Interv. 2024;103:618-625.
    PubMed     Abstract available


  27. ALDOSS O, Porayette P, Mohammad Nijres B
    Bilateral Harmony valve placement in branch pulmonary arteries.
    Catheter Cardiovasc Interv. 2024;103:612-617.
    PubMed     Abstract available


  28. PARK WY, Kim GB, Lee SY, Kim AY, et al
    The adaptability of the Pulsta valve to the diverse main pulmonary artery shape of native right ventricular outflow tract disease.
    Catheter Cardiovasc Interv. 2024;103:587-596.
    PubMed     Abstract available


    February 2024
  29. HAKGOR A, Dursun A, Kahraman BC, Yazar A, et al
    Prognostic impact of main pulmonary artery to ascending aorta diameter ratio in patients with severe aortic stenosis underwent transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31000.
    PubMed     Abstract available


  30. ANDREKA J, Sasi V, Toth GG, Ruzsa Z, et al
    Stent graft implantation from distal radial access-A novel way to treat femoral access site complication during transcatheter aortic valve replacement: A case report.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31001.
    PubMed     Abstract available


  31. BOUSSOFARA A, Godin M, Canville A, Baala B, et al
    Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30969.
    PubMed     Abstract available


  32. HASHEM A, Goldsweig AM
    Funny things are everywhere: Combatting geographic disparities in aortic stenosis care.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30971.
    PubMed    


  33. MAIANI S, Nardi G, Di Mario C, Meucci F, et al
    Patient-specific computer simulation of transcatheter aortic valve replacement in patients with previous mechanical mitral prosthesis: A case series.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30984.
    PubMed     Abstract available


  34. WANG Y, Zhai M, Mao Y, Yang T, et al
    Transcatheter tricuspid valve replacement for functional tricuspid regurgitation after left-sided valve surgery: A single-center experience.
    Catheter Cardiovasc Interv. 2024 Feb 14. doi: 10.1002/ccd.30972.
    PubMed     Abstract available


  35. CHEN Y, Xiao Y, Huang R, Jiang F, et al
    Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis.
    Catheter Cardiovasc Interv. 2024 Feb 14. doi: 10.1002/ccd.30970.
    PubMed     Abstract available


  36. VAN BAKEL PAJ, Ahmed Y, Hou H, Sukul D, et al
    Geographic variation in aortic stenosis treatment and outcomes among Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2024 Feb 8. doi: 10.1002/ccd.30959.
    PubMed     Abstract available


  37. JOLLEY MA, Sulentic A, Amin S, Gupta M, et al
    Introduction of transcatheter edge-to-edge repair in patients with congenital heart disease at a children's hospital.
    Catheter Cardiovasc Interv. 2024;103:326-334.
    PubMed     Abstract available


  38. BOSCAMP NS, Maschietto N, Porras D
    Transcatheter pulmonary valve replacement in surgically-created double-barrel right ventricular outflow tracts: A single center case-series.
    Catheter Cardiovasc Interv. 2024;103:455-463.
    PubMed     Abstract available


    January 2024
  39. GUPTA A, Shrivastava A, Chhikara S, Mamas MA, et al
    Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study).
    Catheter Cardiovasc Interv. 2024;103:51-60.
    PubMed     Abstract available


  40. HEATON J, Imburgio S, Dandu S, Johal A, et al
    Geographic variability and operator trends of transcatheter edge-to-edge repair in the United States.
    Catheter Cardiovasc Interv. 2024;103:147-152.
    PubMed     Abstract available


  41. JIN P, Wang Y, Liu Y, Yang J, et al
    Transapical concomitant transseptal transcatheter closure of a giant mitral paravalvular leak under three-dimensional printing guidance.
    Catheter Cardiovasc Interv. 2024;103:243-247.
    PubMed     Abstract available


  42. CHENG F, Qiao Z, Zhao L, Pu J, et al
    Real-time 3D-3D image fusion of CTA/CBCT roadmap fluoroscopy in the transcatheter mitral intervention.
    Catheter Cardiovasc Interv. 2024;103:230-233.
    PubMed     Abstract available


    December 2023
  43. SAITO T, Kuno T, Ueyama HA, Kampaktsis PN, et al
    Transcatheter edge-to-edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Dec 29. doi: 10.1002/ccd.30944.
    PubMed     Abstract available


  44. DEMIRCI G, Aslan S, Guner A, Demir AR, et al
    Clinical implication of the Naples prognostic score on transcatheter aortic valve replacement in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30929.
    PubMed     Abstract available


  45. FISCHER J, Steffen J, Arlart T, Haum M, et al
    Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30927.
    PubMed     Abstract available


  46. HANSON I, Goldstein JA
    Percutaneous coronary intervention: Before, after, or during TAVR?
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30941.
    PubMed    


  47. CLAEYS MJ, Aminian A, Bartunek J, Bennett J, et al
    Bleeding and thrombotic risk of different antiplatelet regimens posttranscatheter edge-to-edge mitral valve repair in patients with an indication for oral anticoagulation: Results from an all-comers national registry.
    Catheter Cardiovasc Interv. 2023 Dec 11. doi: 10.1002/ccd.30931.
    PubMed     Abstract available


  48. YANG Y, Chen J, Dong L, Lu Y, et al
    Transcatheter mitral valve replacement with Mi-thos system: First-in-human experience.
    Catheter Cardiovasc Interv. 2023 Dec 9. doi: 10.1002/ccd.30926.
    PubMed     Abstract available


  49. BARBASH IM, Wasserstrum Y, Erlebach M, Guetta V, et al
    Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 7. doi: 10.1002/ccd.30921.
    PubMed     Abstract available


  50. JIN Q, Long Y, Zhang G, Pan X, et al
    Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract.
    Catheter Cardiovasc Interv. 2023 Dec 6. doi: 10.1002/ccd.30916.
    PubMed     Abstract available


  51. ORZALKIEWICZ M, Bruno AG, Saia F, Palmerini T, et al
    A novel high-risk aortic root anatomy for right coronary artery occlusion during TAVI.
    Catheter Cardiovasc Interv. 2023;102:1389-1392.
    PubMed     Abstract available


  52. PELLEGRINI C, Freissmuth M, Rheude T, Graas D, et al
    Implantation depth of balloon-expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events.
    Catheter Cardiovasc Interv. 2023;102:1301-1310.
    PubMed     Abstract available


  53. CURIO J, Khokhar AA, Beneduce A, Mylotte D, et al
    Patient-specific commissural alignment for ACURATE neo2 implantation in degenerated surgical bioprostheses.
    Catheter Cardiovasc Interv. 2023;102:1401-1405.
    PubMed     Abstract available


    November 2023
  54. SCHNEEBERGER Y, Sarwari H, Koll B, Demal TJ, et al
    Balloon-expandable transcatheter heart valves for treatment of aortic valve stenosis in patients with large aortic annuli: Evaluation of deployment balloon overfilling strategies.
    Catheter Cardiovasc Interv. 2023 Nov 30. doi: 10.1002/ccd.30922.
    PubMed     Abstract available


  55. ALJABBARY TF, Komatsu I, Ochiai T, Fremes SE, et al
    Cusp overlap method for self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Nov 27. doi: 10.1002/ccd.30910.
    PubMed     Abstract available


  56. ANDROSHCHUK V, Chehab O, Prendergast B, Rajani R, et al
    Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review.
    Catheter Cardiovasc Interv. 2023 Nov 22. doi: 10.1002/ccd.30918.
    PubMed     Abstract available


  57. SHARMA S, Nakamura M
    Percutaneous treatment of mechanical mitral valve thrombosis.
    Catheter Cardiovasc Interv. 2023 Nov 16. doi: 10.1002/ccd.30900.
    PubMed     Abstract available


  58. SANZ SANCHEZ J, Regazzoli D, Barbanti M, Fiorina C, et al
    Impact of balloon post-dilation on valve durability and long-term clinical outcomes after self-expanding transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Nov 13. doi: 10.1002/ccd.30907.
    PubMed     Abstract available


  59. MCCABE JM, Helmy T
    Balloon-assisted leaflet modification: Gaining momentum with innovative approaches.
    Catheter Cardiovasc Interv. 2023;102:962-963.
    PubMed    


  60. WILLEMEN Y, De Backer O
    Stroke prevention in TAVR: A patient-tailored approach may be needed.
    Catheter Cardiovasc Interv. 2023;102:964-965.
    PubMed    


  61. TAN BE, Hashem A, Boppana LKT, Mohamed MS, et al
    Utility of rapid atrial pacing before and after TAVR with balloon-expandable valve in predicting permanent pacemaker implantation.
    Catheter Cardiovasc Interv. 2023;102:919-928.
    PubMed     Abstract available


  62. HERRMANN HC
    Hemodynamics after TAVR matter.
    Catheter Cardiovasc Interv. 2023;102:944-945.
    PubMed    


  63. LEONE PP, Regazzoli D, Pagnesi M, Costa G, et al
    Prosthesis-patient mismatch after transcatheter implantation of contemporary balloon-expandable and self-expandable valves in small aortic annuli.
    Catheter Cardiovasc Interv. 2023;102:931-943.
    PubMed     Abstract available


  64. GORLA R, Tua L, D'Errigo P, Barbanti M, et al
    Incidence and predictors of 30-day and 6-month stroke after TAVR: Insights from the multicenter OBSERVANT II study.
    Catheter Cardiovasc Interv. 2023;102:1122-1131.
    PubMed     Abstract available


  65. STEINBERG ZL, Cabalka AK, Balzer DT, Asnes JD, et al
    Right ventricular outflow tract obstruction associated with neointimal tissue accumulation and distortion of the Harmony TPV25 stent frame: Potential mechanisms and treatment.
    Catheter Cardiovasc Interv. 2023;102:1078-1087.
    PubMed     Abstract available


    October 2023
  66. SHIMAMURA J, Takemoto S, Fukuhara S, Miyamoto Y, et al
    Long-term outcomes after transcatheter aortic valve replacement: Meta-analysis of Kaplan-Meier-derived data.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30854.
    PubMed     Abstract available


  67. DERSHOWITZ L, Lawlor MK, Hamid N, Kampaktsis P, et al
    Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30850.
    PubMed     Abstract available


  68. GEISLER T, Schreieck J, Euper M, Zdanyte M, et al
    Outcomes of patients undergoing edge-to-edge mitral valve repair with the Edwards PASCAL transcatheter valve repair system under conscious sedation.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30866.
    PubMed     Abstract available


  69. WONG N, Fowler D, Lim DS
    Mitral valve-in-valve with 4D intracardiac echocardiography: Procedural and imaging technique.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30897.
    PubMed     Abstract available


  70. SAVVOULIDIS P, Nadir AM, Mechery A, Lawton E, et al
    Routine postaccess-closure angiography to detect vascular complications following transfemoral TAVR.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30894.
    PubMed     Abstract available


  71. MAGYARI B, Kittka B, Gojak I, Kasza G, et al
    Single center experience with the balloon-expandable Myval transcatheter aortic valve system with the first 100 patients: 30-day and 1-year follow-up.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30868.
    PubMed     Abstract available


  72. LORIA JRD, Abdelhafez A, Desch S, Thiele H, et al
    Transcatheter aortic valve implantation in patients with anomalous origin of a coronary artery.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30860.
    PubMed     Abstract available


  73. VELAGAPUDI P, Turagam MK
    Utility of rapid atrial pacing before and after transcatheter aortic valve replacement to predict permanent pacemaker implantation: A valuable piece of the puzzle?
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30880.
    PubMed    


  74. NILSSON K, Buccheri S, Lindback J, Sarno G, et al
    External validation of the Netherlands Heart Registration (NHR) prediction model for early mortality after transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30887.
    PubMed    


  75. MELIOTA G, Lombardi M, Vairo U
    Rapid transesophageal atrial pacing for balloon aortic valvuloplasty in neonates and infants: A new technique for balloon stabilization.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30876.
    PubMed     Abstract available


  76. SPILIAS N, Miyasaka R, Kapadia SR, Krishnaswamy A, et al
    A novel method of prosthetic leaflet modification to enable transcatheter mitral valve-in-valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30872.
    PubMed     Abstract available


  77. SKALIDIS I, Hamilos M, Petousis S, Kochiadakis G, et al
    Successful closure of transcatheter aortic valve replacement-induced Gerbode defect with valve-in-valve technique: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30882.
    PubMed     Abstract available


  78. BROWN B
    Debulking the tricuspid valve with FlowTriever aspiration: A case series.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30888.
    PubMed     Abstract available


  79. MITSUI K, Takagi K, Kakuta T, Noguchi T, et al
    Novel percutaneous intervention technique for obstructed coronary artery after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30865.
    PubMed     Abstract available


  80. WONG N, Lim DS, Yount K, Yarboro L, et al
    Preemptive alcohol septal ablation prior to transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30879.
    PubMed     Abstract available


    September 2023
  81. BARRETT CD, Nickel A, Rosenberg MA, Ream K, et al
    PRIME score for prediction of permanent pacemaker implantation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Sep 21. doi: 10.1002/ccd.30845.
    PubMed     Abstract available


  82. SOUD M, Feit F, Rao S, Bangalore S, et al
    Novel approach to stenting the left anterior descending coronary artery through a retrograde approach via the left internal mammary artery graft in a patient with occlusion of the coronary ostium from a prior aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30844.
    PubMed     Abstract available


  83. ROTH N, Heidel C, Xu C, Hubauer U, et al
    Restoration of von Willebrand factor after transcatheter aortic valve replacement-A possible cause for posttranscatheter aortic valve replacement thrombocytopenia?
    Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30841.
    PubMed     Abstract available


  84. ULLAH W, Sarvepalli D, Kumar A, Zahid S, et al
    Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30832.
    PubMed     Abstract available


  85. HOLZAMER A, Bedogni F, van Wyk P, Barwad P, et al
    Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in patients with extremely large aortic annuli in real-world scenario: First global, multicenter experience.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30820.
    PubMed     Abstract available


  86. HOKKEN TW, Wienemann H, Dargan J, Ginkel DV, et al
    Clinical value of CT-derived simulations of transcatheter-aortic-valve-implantation in challenging anatomies the PRECISE-TAVI trial.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30816.
    PubMed     Abstract available


  87. TRIANTAFYLLIS AS, Desmet W, Tonino PAL
    Diagnosing aberrant circumflex artery prior to transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30819.
    PubMed    


  88. FIORINA C, Massussi M, Ancona M, Montorfano M, et al
    Mid-term outcomes and hemodynamic performance of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: Insights from the bicuSpid TAvi duraBILITY (STABILITY) registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30813.
    PubMed     Abstract available


  89. VAZQUEZ DJL, Lopez GA, Guzman MQ, Cancelo AV, et al
    Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Catheter Cardiovasc Interv. 2023;102:513-520.
    PubMed     Abstract available


    August 2023
  90. GUPTA R, Mahmoudi E, Behnoush AH, Malik AH, et al
    Clinical outcomes and the impact of valve morphology for transcatheter aortic valve replacement in bicuspid aortic valves: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30808.
    PubMed     Abstract available


  91. HAMADA S, Ueyama H, Aikawa T, Kampaktsis PN, et al
    Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2023 Aug 14. doi: 10.1002/ccd.30806.
    PubMed     Abstract available


  92. BAUMBACH A, Patel KP, Kennon S, Ozkor M, et al
    A heart valve dedicated for aortic regurgitation: Review of technology and early clinical experience with the transfemoral Trilogy system.
    Catheter Cardiovasc Interv. 2023 Aug 10. doi: 10.1002/ccd.30795.
    PubMed     Abstract available


  93. WANG C, Wang G, Lu W, Fan X, et al
    MitraClip used for severe mitral regurgitation after surgery for type A aortic dissection combined with Marfan syndrome.
    Catheter Cardiovasc Interv. 2023 Aug 1. doi: 10.1002/ccd.30794.
    PubMed     Abstract available


  94. ZAHR F, Chadderdon S
    Long-term results of M-TEER: A mountain of data with gaps to cross.
    Catheter Cardiovasc Interv. 2023;102:400-401.
    PubMed    


  95. LONG Y, Li W, Chen S, Li M, et al
    Novel arm-width-expandable transcatheter edge-to-edge repair system: Preclinical experiment and first-in-human study.
    Catheter Cardiovasc Interv. 2023;102:301-309.
    PubMed     Abstract available


  96. VELAYUTHAM R, Ahmed AS
    The interplay of cardiac hemodynamics in rheumatic triple valve stenosis.
    Catheter Cardiovasc Interv. 2023;102:375-380.
    PubMed     Abstract available


    July 2023
  97. GROGER M, Zeiml KP, Schneider LM, Rottbauer W, et al
    Impact of concomitant tricuspid regurgitation on outcome after edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2023 Jul 28. doi: 10.1002/ccd.30787.
    PubMed     Abstract available


  98. ZHENG HJ, Yan CJ, Lin DQ, Cheng YB, et al
    Prognostic impact of new permanent pacemaker implantation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30788.
    PubMed     Abstract available


  99. ELBADAWI A, Dang AT, Hamed M, Ali A, et al
    Transcatheter edge-to-edge repair for mitral regurgitation using PASCAL or MitraClip.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30772.
    PubMed     Abstract available


  100. KANE J, Kearney KE, Lombardi WL, Azzalini L, et al
    Electrocautery-assisted re-entry to resolve bilateral aorto-ostial chronic total occlusions due to leaflet obstruction following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30781.
    PubMed     Abstract available


  101. CARETTA G, Menozzi A
    Moderate aortic stenosis in patients with myocardial infarction: A guilty bystander?
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30766.
    PubMed    


  102. GHIZZONI G, Ancona MB, Romano V, Bellini B, et al
    Mind the "commissural drop" when crossing the aortic valve!
    Catheter Cardiovasc Interv. 2023 Jul 18. doi: 10.1002/ccd.30763.
    PubMed    


  103. NATALIS A, Masson JB, Mansour MJ, Asmar MA, et al
    Correlation between measured and predicted mismatch with valve hemodynamics in transcatheter aortic valve replacement: A sex-based analysis.
    Catheter Cardiovasc Interv. 2023 Jul 14. doi: 10.1002/ccd.30764.
    PubMed     Abstract available


  104. ZAMORANO JL, Appleby C, Benamer H, Frankenstein L, et al
    Improving access to transcatheter aortic valve implantation across Europe by restructuring cardiovascular services: An expert council consensus statement.
    Catheter Cardiovasc Interv. 2023 Jul 11. doi: 10.1002/ccd.30760.
    PubMed     Abstract available


  105. FAROUK H, Schone D, Witt C, Bayyud H, et al
    Papillary muscle rupture after transcatheter aortic valve implantation: A case report and literature review.
    Catheter Cardiovasc Interv. 2023 Jul 7. doi: 10.1002/ccd.30761.
    PubMed     Abstract available


  106. LANG FM, Mihatov N, Kriegel J, Nazif TM, et al
    Transcatheter aortic valve-in-valve implantation within stentless landing zones: Procedural insights from a single-center experience.
    Catheter Cardiovasc Interv. 2023 Jul 2. doi: 10.1002/ccd.30755.
    PubMed     Abstract available


    June 2023
  107. BLANKE P, Modine T, Duncan A, Taramasso M, et al
    Anatomic suitability for transapical transcatheter mitral valve implantation using a tether-based device.
    Catheter Cardiovasc Interv. 2023 Jun 24. doi: 10.1002/ccd.30752.
    PubMed     Abstract available


  108. REZKALLA J, Reddy Y, Nishimura RA, Padang R, et al
    Right heart catheterization predictors of symptomatic improvement in patients undergoing transcatheter tricuspid valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 Jun 23. doi: 10.1002/ccd.30754.
    PubMed     Abstract available


  109. YOKOYAMA H, Ochiai T, Saito S
    Infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review.
    Catheter Cardiovasc Interv. 2023 Jun 21. doi: 10.1002/ccd.30751.
    PubMed     Abstract available


  110. KUMAR D, Kesavan V, Lanjewar CP, Sabnis G, et al
    Resolution of aortic regurgitation due to Venturi effect after device closure of ruptured sinus of Valsalva aneurysm.
    Catheter Cardiovasc Interv. 2023 Jun 21. doi: 10.1002/ccd.30746.
    PubMed     Abstract available


  111. AURIGEMMA C, Trani C, D'Errigo P, Barbanti M, et al
    Impact of vascular complications after transcatheter aortic valve implantation. VASC-OBSERVANT II sub-study.
    Catheter Cardiovasc Interv. 2023 Jun 2. doi: 10.1002/ccd.30695.
    PubMed     Abstract available


  112. DE LA TORRE HERNANDEZ JM, Veiga Fernandez G, Barrera S, Sainz Laso F, et al
    Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation.
    Catheter Cardiovasc Interv. 2023;101:1214-1220.
    PubMed     Abstract available


  113. MERDLER I, Bernardo NL, Ben-Dor I, Waksman R, et al
    Cutting balloon for femoral arterial and venus obstructions due to suture-based closure devices: Case series.
    Catheter Cardiovasc Interv. 2023;101:1235-1238.
    PubMed     Abstract available


    May 2023
  114. WOLFRUM M, Moccetti F, Loretz L, Bossard M, et al
    Cerebral embolic protection during transcatheter aortic valve replacement: Insights from a consecutive series with the Sentinel cerebral protection device.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30697.
    PubMed     Abstract available


  115. DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
    Postprocedural trans-mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30698.
    PubMed     Abstract available


  116. HO CB, Vejlstrup NG, De Backer O, Sondergaard L, et al
    Intracardiac echocardiogram to diagnose infective endocarditis after transcatheter aortic valve-in-valve implantation.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30694.
    PubMed     Abstract available


  117. BENEDETTI A, Castaldi G, Poletti E, Moroni A, et al
    Percutaneous treatment of left circumflex coronary artery injury related to mitral valve surgery: Case series and systematic review of the literature.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30693.
    PubMed     Abstract available


  118. SPARGIAS K, Lim DS, Makkar R, Kar S, et al
    Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study.
    Catheter Cardiovasc Interv. 2023 May 13. doi: 10.1002/ccd.30686.
    PubMed     Abstract available


  119. HAMEED I, Ahmed A, Kumar A, Li E, et al
    Mild aortic insufficiency following transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30674.
    PubMed     Abstract available


  120. CALI F, Pagnesi M, Pezzola E, Montisci A, et al
    Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30682.
    PubMed     Abstract available


  121. BUCKLEY AJ, Hensey M, O'Connor S, Maree A, et al
    Dental screening prior to transcatheter versus surgical aortic valve replacement: International Survey of Current Practices.
    Catheter Cardiovasc Interv. 2023 May 7. doi: 10.1002/ccd.30675.
    PubMed    


  122. ABRAHAM B, Farina JM, Fath A, Abdou M, et al
    The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2023 May 5. doi: 10.1002/ccd.30676.
    PubMed     Abstract available


  123. MUSTAFA U, Helmy T
    TAVR for all-Is it time?
    Catheter Cardiovasc Interv. 2023;101:1174-1175.
    PubMed    


  124. SAMIMI S, Chavez Ponce A, Alarouri HS, Shaer AE, et al
    Predictors of hemodynamic response to mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023;101:1120-1127.
    PubMed     Abstract available


  125. MASSUSSI M, Adamo M, Rosati F, Chizzola G, et al
    Coronary artery disease and TAVI: Current evidence on a recurrent issue.
    Catheter Cardiovasc Interv. 2023;101:1154-1160.
    PubMed     Abstract available


    April 2023
  126. YESANTHARAO PS, Etchill EW, Zhou AL, Ong CS, et al
    The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions.
    Catheter Cardiovasc Interv. 2023 Apr 27. doi: 10.1002/ccd.30670.
    PubMed     Abstract available


  127. SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
    Computed tomography-derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2023 Apr 18. doi: 10.1002/ccd.30666.
    PubMed     Abstract available


  128. HOSSEINI M, Lahr BD, Greason KL, Arghami A, et al
    Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion.
    Catheter Cardiovasc Interv. 2023 Apr 10. doi: 10.1002/ccd.30658.
    PubMed     Abstract available


  129. SETH A, Chopra M
    Cusp overlap technique for self-expanding valves: Refining technique defining outcomes.
    Catheter Cardiovasc Interv. 2023;101:963-964.
    PubMed    


    March 2023
  130. MEIJERINK F, Holierook M, Eberl S, Robbers-Visser D, et al
    Dobutamine stress echocardiography during transcatheter edge-to-edge mitral valve repair predicts residual mitral regurgitation.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30645.
    PubMed     Abstract available


  131. HILLEGASS WB
    Vascular closure after transfemoral transcatheter aortic valve replacement: Further randomized trials are justified.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30640.
    PubMed    


  132. ALI N, Hildick-Smith D, Parker J, Malkin CJ, et al
    Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30627.
    PubMed     Abstract available


  133. YAMDA H, Muneuchi J, Sugitani Y, Ezaki H, et al
    Transcatheter atrial septal defect closure late after completion of biventricular circulation in patients with pulmonary atresia intact ventricular septum or critical pulmonary stenosis.
    Catheter Cardiovasc Interv. 2023 Mar 11. doi: 10.1002/ccd.30623.
    PubMed     Abstract available


  134. UEYAMA H, Block PC
    Can patients be selected for transcatheter edge-to-edge repair based on the baseline transmitral gradient?
    Catheter Cardiovasc Interv. 2023;101:830-831.
    PubMed    


    February 2023
  135. WILL M, Schwarz K, Weiss T, Leibundgut G, et al
    The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30601.
    PubMed     Abstract available


  136. SEDHOM R, Dang AT, Elwagdy A, Megaly M, et al
    Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30597.
    PubMed     Abstract available


  137. NATANZON SS, Koseki K, Kaewkes D, Koren O, et al
    Society of thoracic surgeons risk score and left atrial pressure for predicting clinical outcomes among transcatheter mitral edge-to-edge repair patients.
    Catheter Cardiovasc Interv. 2023;101:596-604.
    PubMed     Abstract available


  138. ERDEM S, An SY, McAlister CA, Basra SS, et al
    Suicide left ventricle following protamine: A case report.
    Catheter Cardiovasc Interv. 2023;101:592-595.
    PubMed     Abstract available


    January 2023
  139. LUGO-FAGUNDO N, Pierre K, Adedinsewo D, Simard T, et al
    The impact of baseline transmitral diastolic mean gradient on left atrial pressure reduction in patients undergoing transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 Jan 30. doi: 10.1002/ccd.30577.
    PubMed     Abstract available


  140. ALVAREZ-COVARRUBIAS HA, Joner M, Cassese S, Warmbrunn M, et al
    Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease.
    Catheter Cardiovasc Interv. 2023 Jan 29. doi: 10.1002/ccd.30576.
    PubMed     Abstract available


  141. HIRUMA T, Higuchi R, Saji M, Takamisawa I, et al
    Transcatheter aortic valve replacement-related aortic dissection: A clinical case series.
    Catheter Cardiovasc Interv. 2023 Jan 26. doi: 10.1002/ccd.30574.
    PubMed     Abstract available


  142. SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
    Cusp-overlap versus coplanar view in transcatheter aortic valve implantation with self-expandable valves: A meta-analysis of comparative studies.
    Catheter Cardiovasc Interv. 2023 Jan 19. doi: 10.1002/ccd.30562.
    PubMed     Abstract available


  143. MONTARELLO NJ, Quagliana A, Sondergaard L, De Backer O, et al
    Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2023 Jan 18. doi: 10.1002/ccd.30561.
    PubMed     Abstract available


  144. SAVVOULIDIS P, Nadir AM, Mechery A, Doshi SN, et al
    A very rare vascular complication of the Edwards expandable eSheath during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jan 14. doi: 10.1002/ccd.30557.
    PubMed     Abstract available


  145. BAJORAS V, Dieckus L, Wong I, Laurinaviciene A, et al
    Transcatheter aortic valve implantation in patients with anomalous coronary artery.
    Catheter Cardiovasc Interv. 2023 Jan 14. doi: 10.1002/ccd.30540.
    PubMed     Abstract available


  146. ISMAYL M, Machanahalli Balakrishna A, Elgayesh MM, Thandra A, et al
    Impact of sex on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter mitral valve replacement (TMVR): Analysis from the nationwide readmission database.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30549.
    PubMed     Abstract available


  147. CHEN J, Yang Y, Song W, Feng D, et al
    Transcatheter tricuspid valve-in-valve implantation for degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30554.
    PubMed     Abstract available


  148. SHIBBANI K, Aboulhosn J, Levi D, Mohammad Nijres B, et al
    Hybrid approach for harmony transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2023;101:135-139.
    PubMed     Abstract available


  149. BINGEN BO, Al Amri I, Montero-Cabezas JM, van der Kley F, et al
    Bail out lithotripsy to treat delayed valve-in-valve TAVR-related coronary obstruction.
    Catheter Cardiovasc Interv. 2023;101:97-101.
    PubMed     Abstract available


    December 2022
  150. BARBOSA MOREIRA MJ, Peixoto NADA, Udoma-Udofa OC, de Araujo SLS, et al
    Direct oral anticoagulant versus antiplatelet therapy following transcatheter aortic valve replacement in patients without prior or concurrent indication for anticoagulation: A meta-analysis of randomized studies.
    Catheter Cardiovasc Interv. 2022 Dec 27. doi: 10.1002/ccd.30532.
    PubMed     Abstract available


  151. ORZALKIEWICZ M, Taglieri N, Palmerini T, Saia F, et al
    Overinflation of balloon-expandable valves for transcatheter treatment of pure noncalcified native aortic regurgitation: How much oversizing is needed and achievable?
    Catheter Cardiovasc Interv. 2022 Dec 21. doi: 10.1002/ccd.30529.
    PubMed     Abstract available


  152. ISOGAI T, Agrawal A, Shekhar S, Spilias N, et al
    One-year clinical and echocardiographic outcomes of transcatheter aortic valve replacement with SAPIEN 3 Ultra versus SAPIEN 3.
    Catheter Cardiovasc Interv. 2022 Dec 13. doi: 10.1002/ccd.30515.
    PubMed     Abstract available


  153. OGAMI T, Kliner DE, Toma C, Serna-Gallegos D, et al
    Readmission with infective endocarditis within 90 days following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30508.
    PubMed     Abstract available


  154. ZAID S, Haniyeh AA, Rosenzveig A, Malik A, et al
    Minimalist transcatheter aortic valve replacement misses paravalvular regurgitation: Incidence and echocardiographic distribution of missed paravalvular regurgitation.
    Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30512.
    PubMed     Abstract available


  155. TOMII D, Okuno T, Lanz J, Stortecky S, et al
    Aortic annulus ellipticity and outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Dec 1. doi: 10.1002/ccd.30507.
    PubMed     Abstract available


  156. EL HAJJ M, Krajcer Z
    Percutaneous tricuspid valve repair: A safer alternative to traditional approaches?
    Catheter Cardiovasc Interv. 2022;100:1300-1301.
    PubMed    


  157. MICHAIL M, Cockburn J, Tanseco KVP, Arunothayaraj S, et al
    Feasibility of transcaval access TAVI in morbidly obese patients: A single-center experience.
    Catheter Cardiovasc Interv. 2022;100:1302-1306.
    PubMed     Abstract available


    November 2022
  158. TANNER R, Murphy S, Malone C, McGorrian C, et al
    Correlation of aortic valve annular plane assessment by on-table three-dimensional rotational angiography and preprocedural computed tomography.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30469.
    PubMed     Abstract available


  159. BALDUS S, Schofer N, Hausleiter J, Friedrichs K, et al
    Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30450.
    PubMed     Abstract available


  160. SAMMOUR YM, Lak H, Chahine J, Abushouk A, et al
    Clinical and echocardiographic outcomes with new-onset left bundle branch block after SAPIEN-3 transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30488.
    PubMed     Abstract available


  161. MILLER MS, Cutts J, Donatelle M, Shah K, et al
    Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30471.
    PubMed     Abstract available


  162. ABDULLA A, Jneid H
    Transcatheter therapies for severe aortic and mitral stenosis: To stage or not to stage?
    Catheter Cardiovasc Interv. 2022;100:901-902.
    PubMed    


  163. UEYAMA H, Block PC
    Membranous septum length may not be the answer.
    Catheter Cardiovasc Interv. 2022;100:877-878.
    PubMed    


  164. CHEN CB, Gray WA
    Captured in limbo.
    Catheter Cardiovasc Interv. 2022;100:821-822.
    PubMed    


  165. SATLER LF
    When possible, try to avoid emergent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;100:839-840.
    PubMed    


  166. CHAVARRIA J, Falcao F, Dutra G, Sathananthan J, et al
    Bespoke valve sizing avoids annular rupture in patients treated with a balloon-expandable transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;100:823-831.
    PubMed     Abstract available


  167. FANTA LE, Ewer SM, Gimelli G, Reilly NM, et al
    Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy.
    Catheter Cardiovasc Interv. 2022;100:910-914.
    PubMed     Abstract available


  168. SHAMEKHI J, Hasse C, Veulemans V, Al-Kassou B, et al
    A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR-A multicenter analysis.
    Catheter Cardiovasc Interv. 2022;100:850-859.
    PubMed     Abstract available


  169. RIZIK DG, Goldstein JA
    Intervention for aortic stenosis complicated by shock: Focus on the ventricle.
    Catheter Cardiovasc Interv. 2022;100:1117-1118.
    PubMed    


  170. UEYAMA H, Block PC
    Data are data: Do we need a randomized trial of transcatheter aortic valve replacement for bicuspid valves?
    Catheter Cardiovasc Interv. 2022;100:1132-1133.
    PubMed    


    October 2022
  171. TEBAR MARQUEZ D, Moreno R, Galeote G, Jurado-Roman A, et al
    Transcatheter aortic valve with a novel self-expandable device in patients with previous mechanical mitral valve prosthesis.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30449.
    PubMed     Abstract available


  172. GERCEK M, Irimie AA, Gercek M, Fox H, et al
    Cognitive function in late-stage HFpEF patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30443.
    PubMed     Abstract available


  173. YASHIGE M, Zen K, Takamatsu K, Matoba S, et al
    Additional balloon aortic valvuloplasty to overcome the difficult removal of a self-expandable transcatheter aortic valve system due to valve infolding.
    Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30444.
    PubMed     Abstract available


  174. ASLLANAJ B, Urzua A, Dota A, Levisman J, et al
    Non-surgical extirpation of a non-infectious expanding tricuspid valve mass by percutaneous aspiration thrombectomy.
    Catheter Cardiovasc Interv. 2022 Oct 18. doi: 10.1002/ccd.30428.
    PubMed     Abstract available



  175. Erratum to "Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience".
    Catheter Cardiovasc Interv. 2022 Oct 4. doi: 10.1002/ccd.30409.
    PubMed    


  176. ULLAH W, Zahid S, Muhammadzai H, Khalil F, et al
    Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30407.
    PubMed     Abstract available


  177. KHOKHAR AA, Giannini F, Zlahoda-Huzior A, Mikhail G, et al
    Coronary access after ACURATE neo2 implantation for valve-in-valve TAVR: Insights from ex vivo simulations.
    Catheter Cardiovasc Interv. 2022;100:662-666.
    PubMed    


  178. ZABLAH JE, Dohlen G, Ystgaard MB, Morgan GJ, et al
    Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2022;100:606-611.
    PubMed     Abstract available


    September 2022
  179. ELKARYONI A, Cohen DJ, Lopez JJ, Huded CP, et al
    Trends in invasive treatment of patients hospitalized with aortic stenosis complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30413.
    PubMed     Abstract available


  180. BERKOVITCH A, Segev A, Guetta V, Finkelstein A, et al
    Procedural and long-term outcome among patients undergoing expedited trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30386.
    PubMed     Abstract available


  181. ABUSHOUK AI, Abdelfattah O, Gad MM, Saad A, et al
    Two-year outcomes after transcatheter aortic valve-in-valve implantation in degenerated surgical valves.
    Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30388.
    PubMed     Abstract available


  182. ZAHR F, Chadderdon S, Song H, Sako E, et al
    Contemporary diagnosis and management of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2022 Sep 10. doi: 10.1002/ccd.30364.
    PubMed     Abstract available


  183. HIOKI H, Watanabe Y, Kozuma K, Ryuzaki T, et al
    Validation of reliability and predictivity of membrane septum length measurements for pacemaker need after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30377.
    PubMed     Abstract available


  184. AL-FARRA H, Ravelli ACJ, Henriques JPS, Houterman S, et al
    Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI-NHR risk model.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30398.
    PubMed     Abstract available


  185. ENG MH
    Blocking short-term gains.
    Catheter Cardiovasc Interv. 2022;100:437-438.
    PubMed    


  186. TARANTINI G, Cardaioli F
    SAPIEN 3 transcatheter heart valve in patients with borderline annulus: "stretched better than bigger?"
    Catheter Cardiovasc Interv. 2022;100:422-423.
    PubMed    


  187. HAGEL JA, Batlivala SP, Morales DLS, Shahanavaz S, et al
    An unexpected circular shunt: Novel method to treat semilunar valve insufficiency in a single ventricle patient on mechanical circulatory support.
    Catheter Cardiovasc Interv. 2022;100:395-398.
    PubMed     Abstract available


  188. ZAHID S, Khan MZ, Ullah W, Tanveer Ud Din M, et al
    In-hospital outcomes of TAVR patients with a bundle branch block: Insights from the National Inpatient Sample 2011-2018.
    Catheter Cardiovasc Interv. 2022;100:424-436.
    PubMed     Abstract available


    August 2022
  189. SADAT N, Bruhn D, Scharfschwerdt M, Schaller T, et al
    Impact of high-pressure balloon aortic valvuloplasty on the hydrodynamic result after a transcatheter valve-in-valve procedure.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30359.
    PubMed     Abstract available


  190. OKUNO T, Dangas GD, Hengstenberg C, Sartori S, et al
    Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30370.
    PubMed     Abstract available


  191. MAURINA M, Condello F, Mangieri A, Sanz-Sanchez J, et al
    Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30385.
    PubMed     Abstract available


  192. ZAJARIAS A, Kodali S, McCabe JM, Eng MH, et al
    Real-world experience with concomitant or staged transcatheter aortic and mitral valve replacements using balloon-expandable valves.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30331.
    PubMed     Abstract available


  193. LIU JD, Zhang SY, Wu YQ, Gong R, et al
    Valve implantation for successful sealing of a balloon predilatation-induced annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Aug 3. doi: 10.1002/ccd.30353.
    PubMed     Abstract available


  194. ISOGAI T, Vanguru HR, Krishnaswamy A, Agrawal A, et al
    Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30340.
    PubMed     Abstract available


  195. ENG MH, Zahr F
    When should early discharge post-transcatheter aortic valve replacement be blocked?
    Catheter Cardiovasc Interv. 2022;100:254-255.
    PubMed    


  196. TARANTINI G, Cardaioli F
    Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient.
    Catheter Cardiovasc Interv. 2022;100:243-244.
    PubMed    


  197. HELMY T, Mina G
    Single access TAVR. How "minimalist" do we need to be?
    Catheter Cardiovasc Interv. 2022;100:233-234.
    PubMed    


    July 2022
  198. MEMON S, Goldman S, Hawthorne KM, Gnall EM, et al
    Percutaneous transeptal mitral valve endocarditis debulking with AngioVac aspiration system.
    Catheter Cardiovasc Interv. 2022 Jul 30. doi: 10.1002/ccd.30319.
    PubMed     Abstract available


  199. GALLITTO E, Palmerini T, Saia F, Gargiulo M, et al
    Iliac "paving & cracking" technique for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30344.
    PubMed     Abstract available


  200. DAUTZENBERG L, van Aarle TTM, Stella PR, Emmelot-Vonk M, et al
    The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2022 Jul 13. doi: 10.1002/ccd.30320.
    PubMed     Abstract available


  201. RUSSO M, Chen C, Sethi A, Hakeem A, et al
    TAVR in an XXXL annulus (1057 mm(2) ) with type I bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2022 Jul 6. doi: 10.1002/ccd.30325.
    PubMed     Abstract available


  202. INCI E, Block PC
    Atrial functional mitral regurgitation: A cautionary tale?
    Catheter Cardiovasc Interv. 2022;100:143-144.
    PubMed    


  203. ALASNAG M
    Lifetime management when a redo is in the balance: Valve-in-valve transcatheter aortic valve replacement or resurgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022;100:131-132.
    PubMed    


  204. MOHAMMED M, Nona P, Abou Asala E, Chiang M, et al
    Preclosure of large bore venous access sites in patients undergoing transcatheter mitral replacement and repair.
    Catheter Cardiovasc Interv. 2022;100:163-168.
    PubMed     Abstract available


    June 2022
  205. ELZANATY AM, Maraey A, Elbadawi A, Khalil M, et al
    Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation.
    Catheter Cardiovasc Interv. 2022 Jun 27. doi: 10.1002/ccd.30299.
    PubMed     Abstract available


  206. MEDRANDA GA, Rogers T, Fuery M, Case BC, et al
    Impact of left ventricular outflow tract calcium on valve geometry in self-expanding transcatheter aortic-valve replacement.
    Catheter Cardiovasc Interv. 2022 Jun 20. doi: 10.1002/ccd.30301.
    PubMed     Abstract available


  207. ARONEY NP, Patterson T, Kalogeropoulos A, Allen CJ, et al
    Clinical outcomes following single access transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30246.
    PubMed     Abstract available


  208. ROBERT P, Akodad M, Lattuca B, Gandet T, et al
    Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists.
    Catheter Cardiovasc Interv. 2022 Jun 5. doi: 10.1002/ccd.30248.
    PubMed     Abstract available


  209. TARANTINI G, Fraccaro C
    Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients-Patients' vulnerability still matters.
    Catheter Cardiovasc Interv. 2022;99:2111-2112.
    PubMed    


  210. ONISHI T, Fukutomi M, Ando T, Tobaru T, et al
    A novel "proximal first" Inoue balloon catheter for retrograde aortic valvuloplasty: Initial case report.
    Catheter Cardiovasc Interv. 2022;99:2131-2135.
    PubMed     Abstract available


  211. BECKER MC, Reddy S, Miccio B, Pappas O, et al
    A novel technique for the percutaneous removal of tricuspid valve vegetations utilizing the Inari Flowtriever System.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30294.
    PubMed     Abstract available


    May 2022
  212. TREHAN V, Safal, Gautam A, Bansal A, et al
    Transhepatic balloon mitral valvotomy in mitral stenosis with interrupted inferior vena cava.
    Catheter Cardiovasc Interv. 2022 May 30. doi: 10.1002/ccd.30240.
    PubMed     Abstract available


  213. DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
    Clinical outcomes and predictors in patients with previous cardiac surgery undergoing mitral valve transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30245.
    PubMed     Abstract available


  214. ALACHKAR MN, Muller T, Alnaimi A, Milzi A, et al
    Safety and efficacy of transcatheter mitral valve repair in patients with COPD; results from real-world cohort.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30238.
    PubMed     Abstract available


  215. CORCIONE N, Berni A, Ferraro P, Morello A, et al
    Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30179.
    PubMed     Abstract available


  216. SIMARD T, Reddy YNV, Thaden JJ, Padang R, et al
    Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 10. doi: 10.1002/ccd.30224.
    PubMed     Abstract available


  217. TANG GHL, Dangas GD
    Tailoring the therapy to the patient with mitral and tricuspid regurgitation to avoid adverse long-term outcomes.
    Catheter Cardiovasc Interv. 2022;99:1857-1858.
    PubMed    


  218. POSTALIAN A, Krajcer Z
    Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention.
    Catheter Cardiovasc Interv. 2022;99:1817-1818.
    PubMed    


  219. TARANTINI G, Cardaioli F
    TAVR and stroke: A common evolution.
    Catheter Cardiovasc Interv. 2022;99:1906-1907.
    PubMed    


  220. SEDHOM R, Megaly M, Saad M, Elbadawi A, et al
    Transcatheter edge-to-edge repair of the tricuspid valve: The US experience.
    Catheter Cardiovasc Interv. 2022;99:1859-1866.
    PubMed     Abstract available


  221. TANG GHL, Hooda A, Zaid S, Chuang MY, et al
    Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuli.
    Catheter Cardiovasc Interv. 2022;99:1935-1944.
    PubMed     Abstract available


  222. VENTURI G, Scarsini R, Pighi M, Kotronias RA, et al
    Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI.
    Catheter Cardiovasc Interv. 2022;99:1925-1934.
    PubMed     Abstract available


  223. MOHANTY BD, Coylewright M, Sequeira AR, Shin D, et al
    Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER-2.
    Catheter Cardiovasc Interv. 2022;99:1877-1885.
    PubMed     Abstract available


  224. PORAT A, Gordon M, Perlman G, Planer D, et al
    Mass to voltage ratio index predicts mortality following TAVI.
    Catheter Cardiovasc Interv. 2022;99:1918-1924.
    PubMed     Abstract available


  225. ROTTLANDER D, Beucher H, Ghaddioui KA, Boekstegers P, et al
    Continuous atrial pressure monitoring via steerable guide catheter in transcatheter mitral and tricuspid edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1796-1806.
    PubMed     Abstract available


  226. YA'QOUB L, Gad M, Faza NN, Kunkel KJ, et al
    Sex differences in outcomes of transcatheter edge-to-edge repair with MitraClip: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1819-1828.
    PubMed     Abstract available


  227. ALADIN AI, Case BC, Wermers JP, Rogers T, et al
    Overview of FDA Circulatory System Devices Panel virtual meeting on TriGUARD 3 cerebral embolic protection.
    Catheter Cardiovasc Interv. 2022;99:1789-1795.
    PubMed     Abstract available


    April 2022
  228. BRUNO F, Elia E, D'Ascenzo F, Marengo G, et al
    Valve-in-valve transcatheter aortic valve replacement or re-surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022 Apr 29. doi: 10.1002/ccd.30219.
    PubMed     Abstract available


  229. MEMON MM, Siddiqui AA, Amin E, Shaikh FN, et al
    Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Apr 27. doi: 10.1002/ccd.30213.
    PubMed     Abstract available


  230. KAWAGUCHI T, Miyoshi T, Hayashi M, Ishizu K, et al
    Efficacy of larger valve sizing with underfilling in balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30188.
    PubMed     Abstract available


  231. HOLLOWED J, Akhondi A, Rabbani A, Oncel D, et al
    Single versus double Perclose techniques for vascular closure during transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30176.
    PubMed     Abstract available


  232. HOU S, Pan W, Zhou D, Ge J, et al
    Percutaneous balloon mitral valvuloplasty using veno-arterial loop and neuro-embolic protection for mitral stenosis with thrombus.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30203.
    PubMed     Abstract available


  233. PIRIOU PG, Manigold T, Letocart V, Le Ruz R, et al
    Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30194.
    PubMed     Abstract available


  234. YONG CM, Jaluba K, Batchelor W, Gummipundi S, et al
    Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30182.
    PubMed     Abstract available


  235. ENG MH, Fang HK
    TMVR: Early benefits, late questions.
    Catheter Cardiovasc Interv. 2022;99:1666-1667.
    PubMed    


  236. INCI E, Block PC
    A little leak goes a long way! 5-Year-outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022;99:1590-1591.
    PubMed     Abstract available


  237. LIU X, Chen Y, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in patient with atrial functional mitral regurgitation using novel DragonFly device.
    Catheter Cardiovasc Interv. 2022;99:1691-1695.
    PubMed     Abstract available


  238. TARANTINI G, Rodino G
    Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone.
    Catheter Cardiovasc Interv. 2022;99:1609-1610.
    PubMed    


  239. BRUCE CG, Lederman RJ
    Troubleshooting transcaval access: Honoring our commitments.
    Catheter Cardiovasc Interv. 2022;99:1700-1701.
    PubMed    


  240. BANSAL A, Jaber WA, Reed GW, Puri R, et al
    Surgical versus medical management of infective endocarditis after TAVR.
    Catheter Cardiovasc Interv. 2022;99:1592-1596.
    PubMed     Abstract available


  241. RUGE H, Burri M, Erlebach M, Lange R, et al
    Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR.
    Catheter Cardiovasc Interv. 2022;99:1611-1618.
    PubMed     Abstract available


  242. SEGAR MW, Krajcer Z
    Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap.
    Catheter Cardiovasc Interv. 2022;99:1645-1646.
    PubMed    


  243. GOLDSWEIG AM, Hermiller JB
    Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
    Catheter Cardiovasc Interv. 2022;99:1597-1598.
    PubMed    


    March 2022
  244. ZHU Q, Yuan Z, Xu Y, Chen J, et al
    Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30147.
    PubMed     Abstract available


  245. LE RUZ R, Guerin P, Leurent G, Leroux L, et al
    Mitral valve-in-valve and valve-in-ring procedures: Midterm outcomes in a French nationwide registry.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30161.
    PubMed     Abstract available


  246. ROTTLANDER D, Golabkesh M, Degen H, Ogutcu A, et al
    Mitral valve edge-to-edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30157.
    PubMed     Abstract available


  247. ESCHENBACH LK, Erlebach M, Deutsch MA, Ruge H, et al
    Stroke after transcatheter aortic valve replacement: A severe complication with low predictability.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30143.
    PubMed     Abstract available


  248. SA MP, Jabagi H, Dokollari A, Awad AK, et al
    Early and late outcomes of surgical aortic valve replacement with sutureless and rapid-deployment valves versus transcatheter aortic valve implantation: Meta-analysis with reconstructed time-to-event data of matched studies.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30162.
    PubMed     Abstract available


  249. ABUMEHDI M, Mehta C, Afifi ARSA, Yong SF, et al
    Supravalvular pulmonary stenosis: A risk factor for reintervention in Noonan syndrome with pulmonary valve stenosis.
    Catheter Cardiovasc Interv. 2022 Mar 9. doi: 10.1002/ccd.30148.
    PubMed     Abstract available


  250. MANO TB, Ramos R, Cacela D, Patricio L, et al
    Not all pseudoaneurysms are femoral-A transcaval transcatheter aortic valve replacement rare complication.
    Catheter Cardiovasc Interv. 2022 Mar 3. doi: 10.1002/ccd.30140.
    PubMed     Abstract available


  251. GILANI S, Jneid H
    Reaching the optimal volume-quality balance in transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:1186-1187.
    PubMed    


  252. ENG MH, Fang HK
    Forgotten and unforgiving.
    Catheter Cardiovasc Interv. 2022;99:1287-1288.
    PubMed    


  253. SIMPSON TF, Kheiri B, Chadderdon S, Song HK, et al
    TAVR operator volumes, trends, and geographic variations amongst Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2022;99:1181-1185.
    PubMed     Abstract available


  254. FABRY N, Hendrickson MJ, Arora S, Vavalle JP, et al
    Five-year trends in cause-specific readmissions and cost burden of mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1251-1256.
    PubMed     Abstract available


  255. RANARD LS, Vahl TP, Chung CJ, Sadri S, et al
    Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions.
    Catheter Cardiovasc Interv. 2022;99:1268-1276.
    PubMed     Abstract available


  256. KANG SL, Ramroop R, Manojlovich L, Runeckles K, et al
    Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation?
    Catheter Cardiovasc Interv. 2022;99:1138-1148.
    PubMed     Abstract available


  257. ADAMSON GT, Peng LF, Perry SB, Hanley FL, et al
    Comprehensive diagnostic catheterization in children with major aortopulmonary collateral arteries: A review of catheterization technique and anatomic nomenclature.
    Catheter Cardiovasc Interv. 2022;99:1129-1137.
    PubMed     Abstract available


  258. ABUSHOUK AI, Saad AM, Isogai T, Shekhar S, et al
    Long-term outcomes of transcatheter valve-in-valve replacement for failed aortic bioprosthesis: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1370-1372.
    PubMed    


    February 2022
  259. ASAMI M, Dobner S, Stortecky S, Heg D, et al
    Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Feb 16. doi: 10.1002/ccd.30132.
    PubMed     Abstract available


  260. ELBADAWI A, Tan BE, Sammour Y, Saad M, et al
    Sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement: Insights from the National Readmissions Database.
    Catheter Cardiovasc Interv. 2022 Feb 7. doi: 10.1002/ccd.30072.
    PubMed     Abstract available


  261. VALVO R, Costa G, Tamburino C, Barbanti M, et al
    Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30116.
    PubMed     Abstract available


  262. BRUNNER S, Wolfrum M, Moccetti F, Stampfli SF, et al
    The relevance of tricuspid regurgitation in patients undergoing percutaneous treatment of mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30114.
    PubMed     Abstract available


  263. POSTALIAN A, Krajcer Z
    Facilitating future access to the coronary arteries in patients who need transcatheter aortic valve replacement: A significant step in the right direction.
    Catheter Cardiovasc Interv. 2022;99:932-933.
    PubMed    


  264. GOLDSWEIG AM, Baron SJ
    Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:904-905.
    PubMed     Abstract available


  265. UPADHYAY A, Jneid H
    Predischarge transthoracic echocardiogram after TAVI - Is it really necessary?
    Catheter Cardiovasc Interv. 2022;99:867-868.
    PubMed    


  266. O'NEILL BP, Wang DD, Caranasos TG, Chitwood WR Jr, et al
    Initial in-human experience with the conveyor cardiovascular system for the delivery of large profile transcatheter valve devices.
    Catheter Cardiovasc Interv. 2022;99:943-948.
    PubMed     Abstract available


  267. WELLE GA, El-Sabawi B, Thaden JJ, Greason KL, et al
    Effect of eliminating pre-discharge transthoracic echocardiogram on outcomes after TAVR.
    Catheter Cardiovasc Interv. 2022;99:861-866.
    PubMed     Abstract available


    January 2022
  268. ZHOU D, Chen J, Fan J, Yidilisi A, et al
    Self-expanding transcatheter aortic valve replacement in patients with extremely horizontal aortas.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30094.
    PubMed     Abstract available


  269. OGAMI T, Kurlansky P, Takayama H, Ning Y, et al
    Three-year survival of transcatheter versus surgical aortic valve replacement in dialysis.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30045.
    PubMed     Abstract available


  270. PAULUS MG, Meindl C, Hamerle M, Schach C, et al
    Reduction of radiation exposure during transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30046.
    PubMed     Abstract available


  271. LAWLOR MK, Hamid N, Kampaktsis P, Ning Y, et al
    Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30073.
    PubMed     Abstract available


  272. KATO N, Pellikka PA, Scott CG, Lee AT, et al
    Impact of mitral intervention on outcomes of patients with mitral valve dysfunction and annulus calcification.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30093.
    PubMed     Abstract available


  273. SCHOECHLIN S, Hein M, Brennemann T, Eichenlaub M, et al
    5-Year outcomes after transcatheter aortic valve implantation: Focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30083.
    PubMed     Abstract available


  274. FREIXA X, Estevez-Loureiro R, Pascual I, Carrasco-Chinchilla F, et al
    Procedural and clinical outcomes after repeat edge-to-edge transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30053.
    PubMed     Abstract available


  275. PARAGGIO L, Burzotta F, Graziani F, Aurigemma C, et al
    Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30082.
    PubMed     Abstract available


  276. ADAMO M, Pagnesi M, Popolo Rubbio A, Branca L, et al
    Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30062.
    PubMed     Abstract available


  277. SIMARD T, Lloyd J, Crestanello J, Thaden JJ, et al
    Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30059.
    PubMed     Abstract available


  278. CHIOU A, Yap J, Russo S, Stripe BR, et al
    Understanding repeat hospitalizations in intermediate-to-high risk aortic stenosis patients following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30066.
    PubMed     Abstract available


  279. CAJIGAS HR, Kaptzan T, Lewis B, El-Sabbagh A, et al
    The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30057.
    PubMed     Abstract available


  280. INCI E, Block PC
    Transcatheter valve in valve replacement in stentless prosthetic aortic valves compared to a surgical approach: The lunch is good, but not free!
    Catheter Cardiovasc Interv. 2022;99:193-194.
    PubMed    


  281. OKUYA Y, Moussa ID
    Surgical bailout after transcatheter aortic valve replacement: Hospital procedural volume matters!
    Catheter Cardiovasc Interv. 2022;99:169-170.
    PubMed    


  282. BELARDI J, Lamelas P
    Serious adverse events related to transcatheter aortic valve replacement are infrequent: FORWARD 3-years.
    Catheter Cardiovasc Interv. 2022;99:179-180.
    PubMed    


  283. UPADHYAY A, Jneid H
    Frailty and malnutrition as influential drivers of outcomes after aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:158-159.
    PubMed    


  284. RODRIGUEZ OGANDO A, Ballesteros F, Martinez JLZ
    Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;99:E38-E42.
    PubMed     Abstract available


    December 2021
  285. POPOLO RUBBIO A, Testa L, Granata G, Salvatore T, et al
    Prognostic significance of right ventricle to pulmonary artery coupling in patients with mitral regurgitation treated with the MitraClip system.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30044.
    PubMed     Abstract available


  286. VOGL BJ, Darestani YM, Lilly SM, Thourani VH, et al
    Impact of blood pressure on coronary perfusion and valvular hemodynamics after aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 22. doi: 10.1002/ccd.30052.
    PubMed     Abstract available


  287. OKOH AK, Chen C, Kassotis J, Soliman F, et al
    Utilizing ambulatory electrocardiogram monitoring to reduce conduction related death after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 1. doi: 10.1002/ccd.30027.
    PubMed     Abstract available


  288. MOUSSA ID
    Prediction of left circumflex artery impingement after indirect mitral annuloplasty with the carillon device: "There is more to this than meets the eye!"
    Catheter Cardiovasc Interv. 2021;98:1402-1403.
    PubMed    


  289. SAIA F
    Transcatheter edge-to-edge mitral valve repair: Should we stay tied to COAPT tiers?
    Catheter Cardiovasc Interv. 2021;98:1413-1414.
    PubMed    


  290. SCHNEIDER LM, Nicoleta N, Schepperle N, Paukovitsch M, et al
    Implications of concomitant obstructive or restrictive pulmonary diseases on functional and clinical results after MitraClip.
    Catheter Cardiovasc Interv. 2021;98:E1000-E1006.
    PubMed     Abstract available


    November 2021
  291. WANG DD, O'Neill BP, Caranasos TG, Chitwood WR Jr, et al
    Comparative differences of mitral valve-in-valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves.
    Catheter Cardiovasc Interv. 2021 Nov 29. doi: 10.1002/ccd.30011.
    PubMed     Abstract available


  292. HOKKEN TW, de Ronde M, Wolff Q, Schermers T, et al
    Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program.
    Catheter Cardiovasc Interv. 2021 Nov 27. doi: 10.1002/ccd.30026.
    PubMed     Abstract available


  293. GUNARATHNE A, Tan J, Varcoe R, Bhandari S, et al
    The impact of learning-curve-experience on transcatheter aortic valve replacement outcomes: Insights from the United Kingdom and Ireland all-comers second-generation ACURATE neo transcatheter aortic heart valve registry.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30000.
    PubMed     Abstract available


  294. DAS TM, Shin J, Czarny MJ, Nanavati J, et al
    Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30009.
    PubMed     Abstract available


  295. NEUSER J, Kempf T, Bauersachs J, Widder JD, et al
    Novel self-expanding ALLEGRA transcatheter aortic valve for native aortic stenosis and degenerated bioprosthesis.
    Catheter Cardiovasc Interv. 2021 Nov 17. doi: 10.1002/ccd.30003.
    PubMed     Abstract available


  296. WOLFRUM M, Moccetti F, Piuhola J, Lehtola H, et al
    The Allegra transcatheter heart valve: Short term results from a multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1204-1209.
    PubMed     Abstract available


  297. ENG MH, Abbas AE, Hahn RT, Lee J, et al
    Real world outcomes using 20 mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29 mm)-a propensity matched analysis.
    Catheter Cardiovasc Interv. 2021;98:1185-1192.
    PubMed     Abstract available


  298. ORVIN K, Perl L, Landes U, Dvir D, et al
    Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry.
    Catheter Cardiovasc Interv. 2021;98:E862-E869.
    PubMed     Abstract available


  299. DE MARCO F, Casenghi M, Spagnolo P, Popolo Rubbio A, et al
    A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique.
    Catheter Cardiovasc Interv. 2021;98:E847-E854.
    PubMed     Abstract available


  300. RAZUK V, Camaj A, Cao D, Nicolas J, et al
    Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2021;98:E870-E880.
    PubMed     Abstract available


  301. HAMMAD TA, Abu-Omar Y, Shishehbor MH
    Novel intracardiac echocardiography-guided catheter-based removal of inoperable tricuspid valve vegetation.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.29999.
    PubMed     Abstract available


  302. BAGUR R, Jneid H
    Coronary artery access after aortic valve intervention.
    Catheter Cardiovasc Interv. 2021;98:957-958.
    PubMed    


  303. REILLY JP, Parikh PB
    Valve-in-valve transcatheter aortic valve replacement versus re-do surgical aortic valve replacement: A call for randomized controlled trials.
    Catheter Cardiovasc Interv. 2021;98:948-949.
    PubMed    


  304. ARSLAN F, Gerckens U
    Virtual support for remote proctoring in TAVR during COVID-19.
    Catheter Cardiovasc Interv. 2021;98:E733-E736.
    PubMed     Abstract available


  305. KIM JY, Kim SH, Jang SI
    Bilateral branch pulmonary artery Pulsta valve implantation for treatment of large right ventricular outflow tract in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;98:923-927.
    PubMed     Abstract available


  306. KAPLE RK, Agarwal V, Azarbal A, Sugeng L, et al
    Tricuspid clip implantation using the MitraClip system-A step-by-step guide.
    Catheter Cardiovasc Interv. 2021;98:1006-1019.
    PubMed     Abstract available


    October 2021
  307. AMIN R, Arunothayaraj S, Kirtchuk D, Williams T, et al
    Mobility aids predict mortality after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Oct 22. doi: 10.1002/ccd.29981.
    PubMed     Abstract available


  308. STANOVA V, Rieu R, Cote N, Salaun E, et al
    In vitro Doppler versus catheter transvalvular pressure gradients in balloon-expandable versus self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2021 Oct 11. doi: 10.1002/ccd.29974.
    PubMed     Abstract available


  309. TANG GHL, Sengupta A, Alexis SL, Zaid S, et al
    Conventional versus modified delivery system technique in commissural alignment from the Evolut low-risk CT substudy.
    Catheter Cardiovasc Interv. 2021 Oct 9. doi: 10.1002/ccd.29973.
    PubMed     Abstract available


  310. MATSUMOTO S, Ohno Y, Miyamoto J, Ikari Y, et al
    Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2021 Oct 6. doi: 10.1002/ccd.29960.
    PubMed     Abstract available


  311. MUSUMECI G, Annibali G
    Transcarotid access as a first alternative approach to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021;98:774-775.
    PubMed    


  312. OKUYA Y, Moussa ID
    Hemolysis after transcatheter mitral valve replacement: An underreported phenomenon!
    Catheter Cardiovasc Interv. 2021;98:786-787.
    PubMed    


  313. TARANTINI G, Scotti A
    Bioprosthetic valve fracture for aortic valve-in-valve procedures: Handle with care-extra weapon.
    Catheter Cardiovasc Interv. 2021;98:765-766.
    PubMed    


  314. BRINKMANN C, Abdel-Wahab M, Bedogni F, Bhadra OD, et al
    Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study.
    Catheter Cardiovasc Interv. 2021;98:756-764.
    PubMed     Abstract available


  315. GARCIA-SAYAN E, Raghunathan D, Li FM, Dhoble A, et al
    Initial experience with the fourth generation MitraClip: Outcomes, procedural aspects, and considerations for device selection.
    Catheter Cardiovasc Interv. 2021;98:E626-E636.
    PubMed     Abstract available


  316. SUGIURA A, Weber M, Tabata N, Goto T, et al
    QRS duration is a risk indicator of adverse outcomes after MitraClip.
    Catheter Cardiovasc Interv. 2021;98:E594-E601.
    PubMed     Abstract available


    September 2021
  317. ELBADAWI A, Mahta D, Elgendy IY, Dang AT, et al
    Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2021 Sep 27. doi: 10.1002/ccd.29963.
    PubMed     Abstract available


  318. LEE DU, Han J, Fan GH, Hastie DJ, et al
    The clinical impact of chronic liver disease in patients undergoing transcatheter and surgical aortic valve replacement: Systematic analysis of the 2011-2017 US hospital database.
    Catheter Cardiovasc Interv. 2021 Sep 25. doi: 10.1002/ccd.29952.
    PubMed     Abstract available


  319. MAISANO F, Russo G, Tagliari AP, Gavazzoni M, et al
    Left femoral vein access for transcatheter mitral valve interventions in unfavorable interatrial septal anatomy.
    Catheter Cardiovasc Interv. 2021 Sep 17. doi: 10.1002/ccd.29950.
    PubMed     Abstract available


  320. ATTIZZANI GF, Dallan LAP, Forrest JK, Reardon MJ, et al
    Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry.
    Catheter Cardiovasc Interv. 2021 Sep 17. doi: 10.1002/ccd.29941.
    PubMed     Abstract available


  321. BRIZIDO C, Madeira M, Brito J, Madeira S, et al
    Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis.
    Catheter Cardiovasc Interv. 2021 Sep 10. doi: 10.1002/ccd.29948.
    PubMed     Abstract available


  322. MEDRANDA GA, Rogers T, Ali SW, Zhang C, et al
    Prosthetic valve endocarditis after transcatheter aortic valve replacement in low-risk patients.
    Catheter Cardiovasc Interv. 2021 Sep 10. doi: 10.1002/ccd.29943.
    PubMed     Abstract available


  323. TANG GHL, Dangas GD
    Coronary access after valve-in-valve transcatheter aortic valve replacement: Time for a prospective study?
    Catheter Cardiovasc Interv. 2021;98:605-606.
    PubMed    


  324. ALKHOULI M, Jneid H
    Optimal management of acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2021;98:613-614.
    PubMed    


  325. COBB H, Spray B, Daily J, Dossey A, et al
    Cutting balloon angioplasty on branch pulmonary artery stenosis in pediatric patients.
    Catheter Cardiovasc Interv. 2021;98:526-532.
    PubMed     Abstract available


  326. PETRI N, Lengenfelder B, Voelker W, Nordbeck P, et al
    Interventional closure of aortomitral perforation after TAVR: A case report.
    Catheter Cardiovasc Interv. 2021;98:E483-E485.
    PubMed     Abstract available


    August 2021
  327. CHANG CW, Wadia SK, Rastogi A, Stinis CT, et al
    A unique cause of coronary obstruction after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29919.
    PubMed     Abstract available


  328. FERREIRA DE SALES I, Lodi-Junqueira L, Rafael Sant'Anna Athayde G, Eugenia Alcici M, et al
    Pulmonary artery pressure response to percutaneous mitral valvuloplasty: Associated factors and clinical implications.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29926.
    PubMed     Abstract available


  329. AMGAI B, Patel N, Chakraborty S, Bandyopadhyay D, et al
    30-day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29918.
    PubMed     Abstract available


  330. BRUGGER N, Kassar M, Siontis GCM, Widmer S, et al
    Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2021 Aug 18. doi: 10.1002/ccd.29916.
    PubMed     Abstract available


  331. CHOI CH, Cao K, Malaver D, Kincaid EH, et al
    Redo-aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach.
    Catheter Cardiovasc Interv. 2021 Aug 17. doi: 10.1002/ccd.29921.
    PubMed     Abstract available


  332. GARCIA-GOMEZ M, Delgado-Arana JR, Halim J, De Marco F, et al
    Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29923.
    PubMed     Abstract available


  333. FUKUTOMI M, Hokken T, Wong I, Bieliauskas G, et al
    Prophylactic permanent pacemaker strategy in patients with right bundle branch block undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29914.
    PubMed     Abstract available


  334. BRIGUORI C, Scarpelli M
    The "locking and dragging" technique a facilitated crossover balloon occlusion technique for complex iliofemoral anatomy in transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29915.
    PubMed     Abstract available


  335. MINHA S, Yarkoni Y, Segev A, Finkelstein A, et al
    Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation-A retrospective cohort study.
    Catheter Cardiovasc Interv. 2021 Aug 4. doi: 10.1002/ccd.29891.
    PubMed     Abstract available


  336. NONA P, Mahmood S, Lemor A, Qintar M, et al
    Incidence of acquired ventricular septal defect after transcatheter aortic valve replacement: A large single center experience.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29897.
    PubMed     Abstract available


  337. GUDDETI RR, Pajjuru VS, Walters RW, Garcia SA, et al
    Impact of gender on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter edge-to-edge mitral valve repair: Analysis from the National Readmission Database.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29887.
    PubMed     Abstract available


  338. TARANTINI G, Cardaioli F
    Transcatheter aortic valve replacement and chronic kidney disease: Close friends or sworn enemies?
    Catheter Cardiovasc Interv. 2021;98:328-329.
    PubMed    


  339. FRANZONE A, Esposito G
    Transcatheter aortic valve thrombosis: The more we see the more we know.
    Catheter Cardiovasc Interv. 2021;98:363-364.
    PubMed    


  340. BELARDI JA, Lamelas PM
    New TAVR item added to cart for large scale clinical testing.
    Catheter Cardiovasc Interv. 2021;98:380-381.
    PubMed    


  341. RIMMAUDO F, Angelini G, Condello I
    Thrombocytopenia after TAVI in patients with low body mass index.
    Catheter Cardiovasc Interv. 2021;98:E329-E331.
    PubMed    


  342. KREUTZER J, Armstrong AK, Rome JJ, Zellers TM, et al
    Comparison of the investigational device exemption and post-approval trials of the Melody transcatheter pulmonary valve.
    Catheter Cardiovasc Interv. 2021;98:E262-E274.
    PubMed     Abstract available


  343. KARIMIANPOUR A, Heizer J, Leaphart D, Rier JD, et al
    Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool.
    Catheter Cardiovasc Interv. 2021;98:393-400.
    PubMed     Abstract available


  344. QURESHI WT, Parker M, Walker J, Kakouros N, et al
    Equipment entrapment during redo-TAVR with successful BASILICA procedure.
    Catheter Cardiovasc Interv. 2021;98:E320-E323.
    PubMed     Abstract available


    July 2021
  345. VAN MIEGHEM NM, Windecker S, Manoharan G, Bosmans J, et al
    Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29889.
    PubMed     Abstract available


  346. STAUDACHER DL, Braxmeier K, Stachon P, Hilgendorf I, et al
    Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29885.
    PubMed     Abstract available


  347. URENA M, Lemann T, Chong-Nguyen C, Brochet E, et al
    Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification.
    Catheter Cardiovasc Interv. 2021 Jul 15. doi: 10.1002/ccd.29874.
    PubMed     Abstract available


  348. GOITIA J, Phan DQ, Lee MS, Moore N, et al
    The role of neighborhood disadvantage in predicting mortality in patients after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29872.
    PubMed     Abstract available


  349. OGUZ D, Padang R, Pislaru SV, Nkomo VT, et al
    Clinical predictors and impact of postoperative mean gradient on outcome after transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2021 Jul 10. doi: 10.1002/ccd.29867.
    PubMed     Abstract available


  350. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 8. doi: 10.1002/ccd.29860.
    PubMed     Abstract available


  351. HERMILLER JB JR, Gunnarsson CL, Ryan MP, Moore KA, et al
    The need for future coronary access following surgical or transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 6. doi: 10.1002/ccd.29841.
    PubMed     Abstract available


  352. POSTALIAN A, Krajcer Z
    Transcatheter aortic valve replacement has not helped bridge the racial disparity gap.
    Catheter Cardiovasc Interv. 2021;98:157-158.
    PubMed    


  353. ELGENDY IY, Jneid H
    Worsening renal function after transcatheter aortic valve replacement: Infrequent but deleterious.
    Catheter Cardiovasc Interv. 2021;98:195-196.
    PubMed    


  354. CILINGIROGLU M, Okutucu S
    TAVR in patients with end stage liver and renal disease: Lifesaving and increasing transplant eligibility.
    Catheter Cardiovasc Interv. 2021;98:168-169.
    PubMed    


    June 2021
  355. ISOGAI T, Saad AM, Michihata N, Ahuja KR, et al
    Association of hospital procedural volume with incidence and outcomes of surgical bailout in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 29. doi: 10.1002/ccd.29847.
    PubMed     Abstract available


  356. ROTTLANDER D, Godde M, Degen H, Ogutcu A, et al
    Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography.
    Catheter Cardiovasc Interv. 2021 Jun 25. doi: 10.1002/ccd.29824.
    PubMed     Abstract available


  357. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: A US nationwide study.
    Catheter Cardiovasc Interv. 2021 Jun 19. doi: 10.1002/ccd.29842.
    PubMed     Abstract available


  358. AL-KASSOU B, Shamekhi J, Weber M, Germeroth J, et al
    Frailty, malnutrition, and the endocrine system impact outcome in patients undergoing aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 18. doi: 10.1002/ccd.29821.
    PubMed     Abstract available


  359. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Prognostic impact of echocardiographic mean transvalvular gradients in patients with aortic stenosis and low flow undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jun 17. doi: 10.1002/ccd.29840.
    PubMed     Abstract available


  360. NICOLAS J, Guedeney P, Claessen BE, Mehilli J, et al
    Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.
    Catheter Cardiovasc Interv. 2021 Jun 12. doi: 10.1002/ccd.29807.
    PubMed     Abstract available


  361. SALEEM S, Ullah W, Syed MA, Megaly M, et al
    Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2021 Jun 10. doi: 10.1002/ccd.29789.
    PubMed     Abstract available


  362. ENG MH, Kargoli F, Wang DD, Frisoli TM, et al
    Short- and mid-term outcomes in percutaneous mitral valve replacement using balloon expandable valves.
    Catheter Cardiovasc Interv. 2021 Jun 9. doi: 10.1002/ccd.29783.
    PubMed     Abstract available


  363. MAIER O, Piayda K, Afzal S, Polzin A, et al
    Computed tomography derived predictors of permanent pacemaker implantation after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Jun 2. doi: 10.1002/ccd.29805.
    PubMed     Abstract available


  364. SCHOECHLIN S, Schulz U, Ruile P, Hein M, et al
    Impact of high-sensitivity cardiac troponin T on survival and rehospitalization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 2. doi: 10.1002/ccd.29781.
    PubMed     Abstract available


  365. NICOLAS J, Mehran R
    Access routes in transcatheter aortic valve replacement: All roads lead to Rome but only one is paved.
    Catheter Cardiovasc Interv. 2021;97:1470-1471.
    PubMed    


  366. TARANTINI G, Nai Fovino L
    Treatment of degenerated surgical aortic valve: The importance of having a "lifetime strategy" in younger patients with severe aortic disease.
    Catheter Cardiovasc Interv. 2021;97:1489-1491.
    PubMed    


  367. REILLY JP, Parikh PB
    Transcarotid transcatheter aortic valve replacement: The best alternative?
    Catheter Cardiovasc Interv. 2021;97:1460-1461.
    PubMed    


  368. VUKADINOVIKJ A, Baumgartner E, Bohmann K, Harter D, et al
    Transcatheter valve-in-valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis.
    Catheter Cardiovasc Interv. 2021;97:1472-1478.
    PubMed     Abstract available


  369. KADADO AJ, Islam A
    Iatrogenic atrial septal defect following the MitraClip procedure: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2021;97:E1043-E1052.
    PubMed     Abstract available


  370. IMAMURA T, Narang N
    Improving clinical outcomes following MitraClip.
    Catheter Cardiovasc Interv. 2021;97:E1053.
    PubMed    


    May 2021
  371. EL-SABAWI B, Guerrero ME, Eleid MF, Nkomo VT, et al
    Hemolysis after transcatheter mitral valve replacement in degenerated bioprostheses, annuloplasty rings, and mitral annular calcification: Incidence, patient characteristics, and clinical outcomes.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29779.
    PubMed     Abstract available


  372. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    PubMed     Abstract available


  373. ROMEO FJ, Chiabrando JG, Seropian IM, Raleigh JV, et al
    Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 May 27. doi: 10.1002/ccd.29799.
    PubMed     Abstract available


  374. LIM DS, Smith RL, Zahr F, Dhoble A, et al
    Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2021 May 18. doi: 10.1002/ccd.29749.
    PubMed     Abstract available


  375. MCGRATH DP, Kawabori M, Wessler B, Chen FY, et al
    A meta-analysis of transcarotid versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 May 12. doi: 10.1002/ccd.29768.
    PubMed     Abstract available


  376. LIU X, Pu Z, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly Transcatheter Repair device-First in man implantation in China.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29687.
    PubMed     Abstract available


  377. ARANZULLA TC, Musumeci G
    Clipping mitral valve or atrial fibrillation? Two is better than one!
    Catheter Cardiovasc Interv. 2021;97:1257-1258.
    PubMed    


  378. TARANTINI G, Fraccaro C
    Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:1268-1269.
    PubMed    


  379. CILINGIROGLU M, Marmagkiolis K
    Should the mean left atrial pressure be the ultimate goal after TMVR?
    Catheter Cardiovasc Interv. 2021;97:1250-1251.
    PubMed    


  380. PIERRE K, Adedinsewo DA, Al-Hijji M, Miranda WR, et al
    30-day patient reported outcomes can be predicted by change in left atrial pressure and not change in transmitral gradient following MitraClip.
    Catheter Cardiovasc Interv. 2021;97:1244-1249.
    PubMed     Abstract available


  381. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    PubMed     Abstract available


    April 2021
  382. MORENO R, Baz JA, Moreu J, Berenguer A, et al
    Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra-annular device. The Spanish Allegra valve-in-valve (SAVIV) registry.
    Catheter Cardiovasc Interv. 2021 Apr 23. doi: 10.1002/ccd.29742.
    PubMed     Abstract available


  383. HERRMANN HC, Laskey WK
    Pressure loss recovery in aortic valve stenosis: Contemporary relevance.
    Catheter Cardiovasc Interv. 2021 Apr 22. doi: 10.1002/ccd.29729.
    PubMed     Abstract available


  384. CHANDRA P, Jose J, Mattummal S, Mahajan AU, et al
    Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial.
    Catheter Cardiovasc Interv. 2021 Apr 20. doi: 10.1002/ccd.29733.
    PubMed     Abstract available


  385. OKUNO T, Heg D, Lanz J, Praz F, et al
    Heart valve sizing and clinical outcomes in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29700.
    PubMed     Abstract available


  386. PANCHAL HB, Stone GW, Saxena A, Bursac Z, et al
    In-hospital outcomes after transcatheter edge-to-edge mitral valve repair in patients with chronic kidney disease: An analysis from the 2010-2016 National inpatient sample.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29712.
    PubMed     Abstract available


  387. MARTINEZ-GOMEZ E, McInerney A, Tirado-Conte G, de Agustin JA, et al
    Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29703.
    PubMed     Abstract available


  388. COSTA G, D'Errigo P, Rosato S, Valvo R, et al
    Long-term outcomes of self-expanding versus balloon-expandable transcatheter aortic valves: Insights from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2021 Apr 13. doi: 10.1002/ccd.29701.
    PubMed     Abstract available


  389. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    PubMed     Abstract available


  390. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    PubMed     Abstract available


  391. IRIART X, Guerin P, Jalal Z, Thambo JB, et al
    Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29681.
    PubMed     Abstract available


  392. MUSUMECI G, Colopi M
    Coronary arterial disease in patients undergoing percutaneous edge-to-edge mitral valve repair: Handle with care.
    Catheter Cardiovasc Interv. 2021;97:925-926.
    PubMed    


  393. MAHTTA D, Jneid H
    Paravalvular leak after TAVR: remarkable improvement but not the time to shift focus.
    Catheter Cardiovasc Interv. 2021;97:903-904.
    PubMed    


  394. LANDES U, Kornowski R
    Same day discharge: How much less is more for TAVR patients?
    Catheter Cardiovasc Interv. 2021;97:948-949.
    PubMed    


  395. WELLE GA, El-Sabawi B, Thaden JJ, Greason KL, et al
    Effect of a fourth-generation transcatheter valve enhanced skirt on paravalvular leak.
    Catheter Cardiovasc Interv. 2021;97:895-902.
    PubMed     Abstract available


  396. MODINE T, Vincent F, Delhaye C, Van Belle E, et al
    A dedicated Y-shaped percutaneous ECMO cannula for femoral 2-in-1 vascular access during high-risk procedures.
    Catheter Cardiovasc Interv. 2021;97:959-961.
    PubMed     Abstract available


    March 2021
  397. WEICH H, van Veyeren LM
    A new over-the-wire percutaneous mitral balloon valvuloplasty technique.
    Catheter Cardiovasc Interv. 2021 Mar 31. doi: 10.1002/ccd.29664.
    PubMed     Abstract available


  398. BOEDER NF, Bayer M, Dorr O, Nef HM, et al
    Fusion imaging guided implantation of a Tricento transcatheter heart valve for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 23. doi: 10.1002/ccd.29587.
    PubMed     Abstract available


  399. KABAHIZI A, Sheikh AS, Williams T, Tanseco K, et al
    Elective versus urgent in-hospital transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Mar 13. doi: 10.1002/ccd.29638.
    PubMed     Abstract available


  400. GRANOT Y, Merdler I, Finkelstein A, Arbel Y, et al
    Prognostic implication of right ventricular dysfunction and tricuspid regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Mar 7. doi: 10.1002/ccd.29639.
    PubMed     Abstract available


  401. KITAMURA M, Fam NP, Braun D, Ruf T, et al
    12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29583.
    PubMed     Abstract available


  402. AKHTAR YN, Walker WA, Shakur U, Smith G, et al
    Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users.
    Catheter Cardiovasc Interv. 2021 Mar 1. doi: 10.1002/ccd.29584.
    PubMed     Abstract available


  403. POSTALIAN A, Krajcer Z
    The best option to treat transplant recipients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2021;97:699-700.
    PubMed    


  404. KONERU S, Jneid H
    Rescue valve-in-valve TAVI: Buy one get one free!
    Catheter Cardiovasc Interv. 2021;97:712-713.
    PubMed    


  405. ENG MH, Fang HK
    Transcarotid: A sign from above?
    Catheter Cardiovasc Interv. 2021;97:734-735.
    PubMed    


  406. SINGH GD, Rogers JH, Chen S, Yap J, et al
    Adjunctive use of fluoroscopy during MitraClip implantation reduces procedural complexity: The parallax technique.
    Catheter Cardiovasc Interv. 2021;97:745-754.
    PubMed     Abstract available


  407. KOOISTRA NH, Intan-Goey VMP, Ziviello F, Leenders GE, et al
    Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis.
    Catheter Cardiovasc Interv. 2021;97:E597-E606.
    PubMed     Abstract available


  408. HIBINO M, Tabata M, Ito J, Shibayama K, et al
    Midterm outcomes after the rescue THV-in-THV procedure: Insights from the multicenter prospective OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2021;97:701-711.
    PubMed     Abstract available


    February 2021
  409. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    PubMed     Abstract available


  410. ESTEVEZ-LOUREIRO R, Shuvy M, Taramasso M, Benito-Gonzalez T, et al
    Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry).
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29552.
    PubMed     Abstract available


  411. SHARMA RK, Tuttle MK, Poulin MF, Laham RJ, et al
    CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique.
    Catheter Cardiovasc Interv. 2021 Feb 17. doi: 10.1002/ccd.29544.
    PubMed     Abstract available


  412. CAUGHRON H, Parikh D, Allison Z, Deuse T, et al
    Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease.
    Catheter Cardiovasc Interv. 2021 Feb 17. doi: 10.1002/ccd.29559.
    PubMed     Abstract available


  413. KUMAR A, Sammour Y, Reginauld S, Sato K, et al
    Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
    Catheter Cardiovasc Interv. 2021;97:529-539.
    PubMed     Abstract available


  414. ARSLAN F, Akdim F, Ten Berg JM
    Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructi
    Catheter Cardiovasc Interv. 2021;97:488-492.
    PubMed     Abstract available


  415. SIMPSON TF, Tuohy CV, Rajotte K, Golwala H, et al
    Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR.
    Catheter Cardiovasc Interv. 2021;97:E411-E417.
    PubMed     Abstract available


  416. KHOKHAR AA, Laricchia A, Ponticelli F, Kim WK, et al
    Computed tomography analysis of coronary ostia location following valve-in-valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access.
    Catheter Cardiovasc Interv. 2021 Feb 14. doi: 10.1002/ccd.29503.
    PubMed     Abstract available


  417. THANDRA A, Abusnina W, Jhand A, Shaikh K, et al
    Valve-in-valve transcatheter aortic valve replacement versus redo surgical valve replacement for degenerated bioprosthetic aortic valve: An updated meta-analysis comparing midterm outcomes.
    Catheter Cardiovasc Interv. 2021 Feb 13. doi: 10.1002/ccd.29541.
    PubMed     Abstract available


  418. ADLAM D, Chan N, Baron J, Kovac J, et al
    Aortic stenosis in the time of COVID-19: Development and outcomes of a rapid turnaround TAVI service.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29550.
    PubMed     Abstract available


  419. HALE SM, Jessen M, Banerjee S, Kumbhani DJ, et al
    Successful transcatheter treatment for very late migration of a transcatheter aortic valve into the left ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29547.
    PubMed     Abstract available


  420. KIR D, Shapero K, Chatterjee S, Grimshaw A, et al
    Effect of institutional transcatheter aortic valve replacement volume on mortality: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29502.
    PubMed     Abstract available


  421. BANGALORE S, Alviar CL, Vlahakis S, Keller N, et al
    Tricuspid valve vegetation debulking using the AngioVac system.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29519.
    PubMed     Abstract available


  422. SA MPBO, Simonato M, Van den Eynde J, Cavalcanti LRP, et al
    Balloon versus self-expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29538.
    PubMed     Abstract available


  423. YONG MS, Camuglia AC, Cox SV, Cole CM, et al
    Plaster pipes and crystalized graphite: Open transventricular transcatheter aortic valve replacement for failed mechanical aortic valve prostheses in the porcelain aorta.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29465.
    PubMed     Abstract available


  424. AL-HIJJI MA, ElHajj S, El Sabbagh A, Alkhouli MA, et al
    Temporal outcomes of transcatheter mitral valve replacement in native mitral valve disease with annular calcification.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29515.
    PubMed     Abstract available


  425. VAN WIECHEN MP, Kroon H, Hokken TW, Ooms JF, et al
    Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29506.
    PubMed     Abstract available


  426. SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
    Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
    PubMed     Abstract available


  427. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    In-hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study.
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29517.
    PubMed     Abstract available


  428. ERINNE I, Sethi A, Johannesen J, Kassotis J, et al
    Racial disparities in the treatment of aortic stenosis: Has transcatheter aortic valve replacement bridged the gap?
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29487.
    PubMed     Abstract available


  429. POSTALIAN A, Krajcer Z
    How often is urgent surgery required to address transcatheter mitral valve repair complications?
    Catheter Cardiovasc Interv. 2021;97:342-343.
    PubMed    


  430. ENG MH, Verma DR
    Mitral valve-in-ring: Simply complicated.
    Catheter Cardiovasc Interv. 2021;97:359-360.
    PubMed    


  431. MUSUMECI G, Annibali G
    Access site vascular complications in TAVR: Is this the right time?
    Catheter Cardiovasc Interv. 2021;97:333-334.
    PubMed    


  432. RUGE H, Burri M, Erlebach M, Lange R, et al
    Access site related vascular complications with third generation transcatheter heart valve systems.
    Catheter Cardiovasc Interv. 2021;97:325-332.
    PubMed     Abstract available


  433. KARAHALIOS B, Breinholt JP, Little SH, Huie Lin C, et al
    Intentional bioprosthetic tricuspid valve fracture to facilitate transcatheter valve-in-valve deployment.
    Catheter Cardiovasc Interv. 2021;97:361-364.
    PubMed     Abstract available


    January 2021
  434. SIMARD T, Alqahtani F, Hibbert B, Mamas MA, et al
    Sex-specific in-hospital outcomes of transcatheter aortic valve replacement with third generation transcatheter heart valves.
    Catheter Cardiovasc Interv. 2021 Jan 31. doi: 10.1002/ccd.29499.
    PubMed     Abstract available


  435. SAMMOUR Y, Kerrigan J, Banerjee K, Gajulapalli RD, et al
    Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience.
    Catheter Cardiovasc Interv. 2021 Jan 29. doi: 10.1002/ccd.29496.
    PubMed     Abstract available


  436. MYAT A, Mouy F, Buckner L, Cockburn J, et al
    Survival relative to pacemaker status after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29498.
    PubMed     Abstract available


  437. CARRETERO BELLON JM, Morr IC, Merchan EF, Prada FH, et al
    Expanding percutaneous treatment of mitral valve diseases: Transcatheter closure of mitral valve leaflet perforation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29467.
    PubMed     Abstract available


  438. QINTAR M, Wang DD, O'Neill WW, O'Neill B, et al
    Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of "Eustachian ridge?"
    Catheter Cardiovasc Interv. 2021 Jan 25. doi: 10.1002/ccd.29461.
    PubMed     Abstract available


  439. ITO N, Zen K, Kuwabara K, Matoba S, et al
    Recapture failure in transcatheter aortic valve replacement with CoreValve Evolut R.
    Catheter Cardiovasc Interv. 2021 Jan 22. doi: 10.1002/ccd.29580.
    PubMed     Abstract available


  440. SCHOTT JP, Dixon SR, Goldstein JA
    Disparate impact of severe aortic and mitral regurgitation on left ventricular dilation.
    Catheter Cardiovasc Interv. 2021 Jan 20. doi: 10.1002/ccd.29455.
    PubMed     Abstract available


  441. MEIJERINK F, Koch KT, de Winter RJ, Robbers-Visser D, et al
    Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome.
    Catheter Cardiovasc Interv. 2021 Jan 18. doi: 10.1002/ccd.29464.
    PubMed     Abstract available


  442. NIJENHUIS VJ, Meyer A, Brouwer J, Mahmoodi BK, et al
    The effect of transcatheter aortic valve implantation approaches on mortality.
    Catheter Cardiovasc Interv. 2021 Jan 14. doi: 10.1002/ccd.29456.
    PubMed     Abstract available


  443. ROHM CL, Farhat S, Al-Hijji M, Goel K, et al
    Endovascular snare technique to facilitate delivery of self-expanding valve during transcatheter aortic valve-in-valve replacement in angulated aortas: A case series.
    Catheter Cardiovasc Interv. 2021 Jan 11. doi: 10.1002/ccd.29459.
    PubMed     Abstract available


  444. ELBADAWI A, Ugwu J, Elgendy IY, Megaly M, et al
    Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients.
    Catheter Cardiovasc Interv. 2021 Jan 5. doi: 10.1002/ccd.29426.
    PubMed     Abstract available


  445. MARMAGKIOLIS K, Cilingiroglu M
    TAVR in cancer; healing the sickest of the sick.
    Catheter Cardiovasc Interv. 2021;97:165-166.
    PubMed    


  446. SAKAI K, Ohno Y, Miyamoto J, Horinouchi H, et al
    Optimizing self-expandable transcatheter heart valve sizing in patients with small sinus of Valsalva.
    Catheter Cardiovasc Interv. 2021;97:E168-E171.
    PubMed     Abstract available


  447. VOGT JC, Michelena HI, Nishimura RA, Nkomo VT, et al
    Diastolic blood pressure predicts outcomes after aortic paravalvular leak closure.
    Catheter Cardiovasc Interv. 2021;97:E79-E87.
    PubMed     Abstract available


    December 2020
  448. PERDONCIN E, Greenbaum AB, Grubb KJ, Babaliaros VC, et al
    Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era.
    Catheter Cardiovasc Interv. 2020 Dec 31. doi: 10.1002/ccd.29453.
    PubMed     Abstract available


  449. TANSECO KV, Alsanjari O, Cockburn J, Hildick-Smith D, et al
    Amplatzer device closure of femoral pseudoaneurysm after transcatheter aortic valve implantation: An alternative to surgical repair.
    Catheter Cardiovasc Interv. 2020 Dec 22. doi: 10.1002/ccd.29424.
    PubMed     Abstract available


  450. PHAN DQ, Lee MS, Aharonian V, Mansukhani P, et al
    Association between mid-term worsening renal function and mortality after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29429.
    PubMed     Abstract available


  451. LECLERCQ F, Choteau R, Cayla G, Chamard C, et al
    Transcarotid versus transfemoral access in patients undergoing transcatheter aortic valve replacement with complex aortofemoral anatomy.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29438.
    PubMed     Abstract available


  452. ANCONA MB, Beneduce A, Romano V, Buzzatti N, et al
    Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29432.
    PubMed     Abstract available


  453. AMAT-SANTOS IJ, Santos-Martinez S, Conradi L, Taramasso M, et al
    Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29423.
    PubMed     Abstract available


  454. KRAJCER Z, Costello B
    Effect of concomitant aortic regurgitation on early hypoattenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020;96:1498-1499.
    PubMed     Abstract available


    November 2020
  455. GIFFT K, Omran J, Ghrair F, Allaham H, et al
    Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip).
    Catheter Cardiovasc Interv. 2020 Nov 28. doi: 10.1002/ccd.29404.
    PubMed     Abstract available


  456. BAEKKE PS, Jorgensen TH, Sondergaard L
    Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29403.
    PubMed     Abstract available


  457. SUGIURA A, Weber M, Tabata N, Goto T, et al
    Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Nov 19. doi: 10.1002/ccd.29390.
    PubMed     Abstract available


  458. RZUCIDLO J, Jaspan V, Paone D, Jilaihawi H, et al
    Long-term outcomes after transcatheter aortic valve replacement with minimal contrast in chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29378.
    PubMed     Abstract available


  459. BENETOS G, Karmpalioti M, Drakopoulou M, Stathogiannis K, et al
    One-year clinical and echocardiographic outcomes of direct implantation of a self-expanding valve.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29389.
    PubMed     Abstract available


  460. ALARFAJ M, Jain T, Krepp J
    Transcatheter mitral valve thrombosis: A case report and literature review.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29374.
    PubMed     Abstract available


  461. SAYAH N, Simon F, Garceau P, Ducharme A, et al
    Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29365.
    PubMed     Abstract available


  462. ARORA S, Lahewala S, Zuzek Z, Thakkar S, et al
    Transcatheter aortic valve replacement in aortic regurgitation: The U.S. experience.
    Catheter Cardiovasc Interv. 2020 Nov 9. doi: 10.1002/ccd.29379.
    PubMed     Abstract available


  463. CASENGHI M, Gorla R, Popolo Rubbio A, De Marco F, et al
    One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system.
    Catheter Cardiovasc Interv. 2020 Nov 6. doi: 10.1002/ccd.29353.
    PubMed     Abstract available


  464. CHIARITO M, Mehran R
    Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough?
    Catheter Cardiovasc Interv. 2020;96:1110-1112.
    PubMed    


  465. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    PubMed     Abstract available


  466. TARANTINI G, Masiero G
    Combined edge-to-edge tricuspid and mitral valve repair: Promising but still a long and bumpy road.
    Catheter Cardiovasc Interv. 2020;96:1331-1332.
    PubMed    


  467. POSTALIAN A, Krajcer Z
    Preventing tricuspid valve injury during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2020;96:1294-1295.
    PubMed     Abstract available


    October 2020
  468. ABU KHADIJA H, Ayyad O, Haberman D, Gandelman G, et al
    Contemporary transcatheter aortic valve implantation related thrombocytopenia.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29325.
    PubMed     Abstract available


  469. SIMONETTO F, Purita PAM, Malerba M, Barbierato M, et al
    Surgical redo versus transseptal or transapical transcatheter mitral valve-in-valve implantation for failed mitral valve bioprosthesis.
    Catheter Cardiovasc Interv. 2020 Oct 13. doi: 10.1002/ccd.29324.
    PubMed     Abstract available


  470. CHAWLA KK, Huang X, Hadro N, Islam AM, et al
    A novel technique to manage transcatheter aortic valve embolization.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29279.
    PubMed     Abstract available


  471. SAMMOUR Y, Sato K, Kumar A, Gajulapalli RD, et al
    Impact of baseline conduction abnormalities on outcomes after transcatheter aortic valve replacement with SAPIEN-3.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29309.
    PubMed     Abstract available


  472. NICOLAS J, Claessen BE, Cao D, Sartori S, et al
    Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29276.
    PubMed     Abstract available


  473. KORBER MI, Friedrichs KP, Aydin F, Pfister R, et al
    Impact of cleft-like indentations on procedural outcome of percutaneous edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29286.
    PubMed     Abstract available


  474. MISUMIDA N, Guerrero M, Pislaru SV, Alkhouli M, et al
    Hemodynamic response to transseptal transcatheter mitral valve replacement in patients with severe mitral stenosis due to severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29285.
    PubMed     Abstract available


  475. TARANTINI G, Nai Fovino L
    TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more.
    Catheter Cardiovasc Interv. 2020;96:956-957.
    PubMed    


  476. OOI YS, Gray WA
    One in one equals two.
    Catheter Cardiovasc Interv. 2020;96:987-988.
    PubMed    


  477. ARANZULLA TC, Musumeci G
    Remove the obstacle and get into the flow!
    Catheter Cardiovasc Interv. 2020;96:979-980.
    PubMed    


    September 2020
  478. LUNARDI M, Franzese I, Faggian G, Ribichini FL, et al
    Hybrid treatment of aortic aneurism, type-A dissection, and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Sep 26. doi: 10.1002/ccd.29303.
    PubMed     Abstract available


  479. HOSHI T, Hiraya D, Sato A, Ieda M, et al
    Potential risk of perioperative thromboembolism in patients with antiphospholipid syndrome who undergo transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2020 Sep 25. doi: 10.1002/ccd.29300.
    PubMed     Abstract available


  480. PATEL ND, Nageotte S, Ing FF, Armstrong AK, et al
    Procedural, pregnancy, and short-term outcomes after fetal aortic valvuloplasty.
    Catheter Cardiovasc Interv. 2020;96:626-632.
    PubMed     Abstract available


  481. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed     Abstract available


  482. PULS M, Huenlich M, Boekstegers P, Lubos E, et al
    Implantation of one versus two MitraClips in the German TRAMI registry: Is more always better?
    Catheter Cardiovasc Interv. 2020;96:E360-E368.
    PubMed     Abstract available


  483. JOHNSON DT, Fournier S, Kirkeeide RL, De Bruyne B, et al
    Phasic pressure measurements for coronary and valvular interventions using fluid-filled catheters: Errors, automated correction, and clinical implications.
    Catheter Cardiovasc Interv. 2020;96:E268-E277.
    PubMed     Abstract available


  484. PAL N, Jones D, Rice G, Sinhal A, et al
    Case report describing late balloon dilatation as a treatment for paravalvular leak with intuity elite rapid deployment valve.
    Catheter Cardiovasc Interv. 2020;96:E292-E294.
    PubMed     Abstract available


  485. SATHANANTHAN J, Hensey M, Fraser R, Landes U, et al
    Implications of hydrodynamic testing to guide sizing of self-expanding transcatheter heart valves for valve-in-valve procedures.
    Catheter Cardiovasc Interv. 2020;96:E332-E340.
    PubMed     Abstract available


    August 2020
  486. OLIVEIRA FA, Lemos PA
    TAVR patients count on their thrombocytes: Platelets count is accountable for the outcomes!
    Catheter Cardiovasc Interv. 2020;96:422-423.
    PubMed     Abstract available


  487. MUSUMECI G, Albani S
    US-guided vascular access and left ventricular rapid pacing in TAVR: Two simple points that may improve patients' outcomes.
    Catheter Cardiovasc Interv. 2020;96:440-441.
    PubMed     Abstract available


  488. TAN W, Calfon Press M, Lluri G, Aboulhosn J, et al
    Percutaneous edge-to-edge repair for common atrioventricular valve regurgitation in a patient with heterotaxy syndrome, single ventricle physiology, and unbalanced atrioventricular septal defect.
    Catheter Cardiovasc Interv. 2020;96:384-388.
    PubMed     Abstract available


  489. LAUCK SB, Sathananthan J, Park J, Achtem L, et al
    Post-procedure protocol to facilitate next-day discharge: Results of the multidisciplinary, multimodality but minimalist TAVR study.
    Catheter Cardiovasc Interv. 2020;96:450-458.
    PubMed     Abstract available


    July 2020
  490. KHAN MZ, Khan MU, Kalra A, Krupica T, et al
    Transcatheter versus surgical aortic valve replacement in patients with end stage renal disease.
    Catheter Cardiovasc Interv. 2020 Jul 7. doi: 10.1002/ccd.29109.
    PubMed     Abstract available


  491. LARICCHIA A, Mangieri A, Colombo A, Giannini F, et al
    Perceval sutureless valve migration treated by valve-in-valve with a CoreValve Evolut Pro.
    Catheter Cardiovasc Interv. 2020;96:225-227.
    PubMed     Abstract available


  492. AKKAYA E, Sozener K, Rixe J, Tsiakou M, et al
    Venous access closure using a purse-string suture without heparin antagonism or additional compression after MitraClip implantation.
    Catheter Cardiovasc Interv. 2020;96:179-186.
    PubMed     Abstract available


  493. STRIPE BR, Singh GD, Smith T, Rogers JH, et al
    Retrieval of a MitraClip from the left atrium using a two-snare technique: Case report and review of the literature.
    Catheter Cardiovasc Interv. 2020;96:210-214.
    PubMed     Abstract available


    June 2020
  494. TARANTINI G, Nai Fovino L
    Preexisting diastolic dysfunction in patients undergoing TAVR matters-But what about diastole the day after TAVR?
    Catheter Cardiovasc Interv. 2020;95:1338-1339.
    PubMed    


    May 2020
  495. KIMMELSTIEL C, Rowin EJ
    Fixed, high-volume alcohol dose for septal ablation: High risk with no benefit.
    Catheter Cardiovasc Interv. 2020;95:1219-1220.
    PubMed     Abstract available


  496. KASHTANOV MG, Rzhannikova AD, Chernyshev SD, Kardapoltsev LV, et al
    Outcomes of hypertrophic obstructive cardiomyopathy patients undergoing alcohol septal ablation with a standard 3 mL dose of ethanol: Focus on long-term safety.
    Catheter Cardiovasc Interv. 2020;95:1212-1218.
    PubMed     Abstract available


    April 2020
  497. BUTERA G, Lucchese G, Austin C, Frigiola A, et al
    Hybrid trans-apical atrioventricular valve-in-valve implantation in Fontan circulation.
    Catheter Cardiovasc Interv. 2020;95:950-953.
    PubMed     Abstract available


  498. JONES BM, Jobanputra Y, Krishnaswamy A, Mick S, et al
    Rapid ventricular pacing during transcatheter valve procedures using an internal device and programmer: A demonstration of feasibility.
    Catheter Cardiovasc Interv. 2020;95:1042-1048.
    PubMed     Abstract available


  499. EITAN A, Brinkmann C, Haselbach T, Witt J, et al
    Does valve in valve TAVR carry a higher risk for thromboembolic events compared to native valve TAVR?
    Catheter Cardiovasc Interv. 2020;95:1017-1021.
    PubMed     Abstract available


    March 2020
  500. RUGE H, Erlebach M, Lieberknecht E, Lange R, et al
    Successful treatment of a paravalvular leak with balloon cracking and valve-in-valve TAVR.
    Catheter Cardiovasc Interv. 2020;95:859-862.
    PubMed     Abstract available


  501. GODART F, Baudelet JB, Soquet J, Onorato E, et al
    Antegrade transcatheter closure of a dehiscence of pulmonary bioprosthesis after pulmonary valve replacement with the Occlutech paravalvular leak device.
    Catheter Cardiovasc Interv. 2020;95:855-858.
    PubMed     Abstract available


  502. EL-SABAWI B, Nishimura RA, Guerrero ME, Rihal CS, et al
    Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.
    Catheter Cardiovasc Interv. 2020;95:830-837.
    PubMed     Abstract available


    February 2020
  503. SERFAS JD, Turek J, Haney J, Krasuski RA, et al
    Hybrid transcatheter pulmonary valve replacement with a SAPIEN S3 valve after pulmonary artery banding via left lateral thoracotomy.
    Catheter Cardiovasc Interv. 2020;95:E78-E83.
    PubMed     Abstract available


  504. YAP J, Chen S, Stripe BR, Smith TWR, et al
    Transseptal access for left heart structural interventions in the setting of prior atrial septal defect closure.
    Catheter Cardiovasc Interv. 2020;95:414-419.
    PubMed     Abstract available


  505. ALMALLA M, Kersten A, Altiok E, Marx N, et al
    Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Catheter Cardiovasc Interv. 2020;95:357-362.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.